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Chronic kidney disease (CKD) is a significant cause of disability and death in Saint 
Lucia. The incidence of CKD is disproportionately higher among individuals who are 
socially and financially disadvantaged. New evidence suggests that in resource-poor 
countries, government subsidization programs for dialysis treatment aid in the delay of 
disease progression and its associated costs. The purpose of this study was to examine the 
relationship between health insurance, government subsidization, employment, and 
dialysis utilization for CKD patients and the efficacy of subsidization for dialysis in Saint 
Lucia. The study included a retrospective cohort of 979 moderate-to-severe CKD patients 
from secondary data obtained from the Ministry of Health’s renal registry database. 
Dialysis utilization among CKD patients was compared to usage across payment 
methods. Categorical data were measured and compared using crosstabulations, chi-
square analyses, frequency distributions, and counts between groups. Logistic regression 
was applied to control for covariates and compare independent variables. A statistically 
significant relationship was found between employment and subsidization and dialysis 
utilization among CKD patients but not between insurance and dialysis utilization. 
Dialysis utilization among CKD patients in Saint Lucia was heavily influenced by 
government subsidization. Policy makers, healthcare officials, and other stakeholders 
may obtain information from this study that they can use to develop future initiatives for 
payment models and disease management of CKD in Saint Lucia, which may alleviate 
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Section 1: Foundation of the Study and Literature Review 
Introduction 
Chronic kidney disease (CKD) has become a major contributing factor to the 
global burden of disease, with an estimated global prevalence of 11-13% (Hill et al., 
2016; Morton et al., 2017; Nicoll et al., 2018). The prevalence of obesity, diabetes, 
hypertension, and CKD in aging populations has a high economic cost for health systems 
(Crews et al., 2017; Hill et al., 2016). Despite the increasing prevalence and burden, CKD 
remains a low priority within the public health response to noncommunicable diseases in 
low-and middle-income countries (LMICs; George et al., 2017; Stanifer et al., 2016). 
According to Nicoll (2018), CKD is a significant cause of death and disability 
worldwide. Consequently, the incidence of CKD is disproportionately higher among 
socially disadvantaged individuals and leads to many negative consequences for these 
individuals and their families (Morton et al., 2017). CKD rates are rising in Saint Lucia 
compared to the United States due primarily to lifestyle factors such as diet and exercise 
(Business View Caribbean, 2019; Ministry of Health, 2019). Additionally, a report by the 
Institute for Health Metrics and Evaluation (2018) revealed that some of the top risk 
factors for death and disability in Saint Lucia in 2017, as shown in Figure 1, were 





Top 10 Risks Contributing to Death and Disability in Saint Lucia, 2007-2017 
 
 
Note. Figure 1 illustrates the top 10 risks contributing to death and disability in Saint 
Lucia, all ages combined, for 2007-2017. The graphic shows 2007 and 2017 rankings and 
percentage changes. From Saint Lucia, by Institute for Health Metrics and Evaluation, 
2018 (http://www.healthdata.org/saint-lucia). CC BY-NC-ND 4.0. 
CKD is a progressive noncommunicable disease that cannot be reversed and can 
lead to kidney failure or end-stage renal disease (ESRD) if it is not detected and treated 
early (Centers for Disease Control and Prevention [CDC], 2019). Significant CKD causes 
among adults in Saint Lucia are diabetes and high blood pressure (Pan American Health 
Organization [PAHO], 2019). Other risk factors include heart disease, obesity, past 
damage to the kidneys, a family history of CKD, and old age (Caribbean Renal Registry, 
2018; Government of Saint Lucia, 2018). CKD has varying severity levels, and treatment 
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slows progression (Caribbean Renal Registry, 2018; Hill et al., 2016; National Kidney 
Foundation [NKF], 2019). 
The Caribbean is home to approximately 40 million people, and the majority of 
the population lives on islands considered LMICs, such as Saint Lucia. Kramer (2018) 
noted that economic, demographic, and health trends in the Caribbean region generally 
mirror global changes. A study of the English-speaking Caribbean revealed that CKD is 
associated with high morbidity and mortality and places a significant economic burden 
and decreased quality of life on affected patients (Meade et al., 2018). In a study carried 
out in Jamaica, the largest English-speaking country in the Caribbean, in 2007, of the 968 
patients diagnosed with CKD in that year, 576 were on dialysis (Labonté et al., 2017). In 
that same year, Antigua reported 43 patients on dialysis (Meade et al., 2018). In 2015, 
Saint Lucia had an estimated 85 patients on dialysis between Victoria Hospital and St. 
Jude Hospital, with an estimated 85 on the waiting list (Government Information Service 
[GIS], 2019). Although most of the English-speaking Caribbean offers dialysis treatment 
for CKD patients, Jamaica and Trinidad and Tobago are the only two islands offering 
renal transplantation (Labonté et al., 2017). Negative cultural attitudes toward organ 
donations are considered a contributing factor to the lack of renal transplantation in other 
countries in the region (Kramer et al., 2018). 
Consequently, the financial demands of CKD on governments and healthcare 
systems reflect global dialysis utilization trends. According to Pallayova et al. (2018), 
despite the remarkable global epidemiological changes occurring over the past 30 years, 
CKD's prevalence and the associated clinical and economic burden have risen worldwide. 
4 
 
Additionally, they noted that the fastest growth rates were occurring in LMICs, which 
accounts for the increased burden on these countries' governments.  
Over the years, Saint Lucia has implemented various programs to address the 
CKD health crisis (GIS, 2016). The Ministry of Health has implemented free CKD 
screenings and lifestyle and nutrition services at the local level. The transfer of the 
national dialysis clinic to the Owen King European Union Hospital in 2008 was a 
response to long waiting lists for dialysis treatment (GIS, 2015). Despite these initiatives, 
more demands are placed on an already tasked health system due to the development of 
comorbidities, such as hypertension, diabetes, heart failure, cardiovascular diseases, 
atherosclerosis, and lipid disorders (Kramer et al., 2018). Through the Ministries of 
Health and Finance, the Government of Saint Lucia implemented a dialysis subsidization 
program for uninsured CKD patients that covers a significant part of dialysis treatment 
(GIS, 2016). The Healthcare Amnesty Program includes medication and doctor visits 
(GIS, 2016). According to Dr. Merle Clarke, the chief nephrologist on the island, these 
efforts have contributed significantly to CKD patients' care in Saint Lucia. However, the 
increasing numbers of patients demand more resources and support systems (Victoria 
Hospital, 2019).  
In this section, I provide an overview of Saint Lucia’s healthcare system and CKD 
management on the island. Next, the problem statement, the purpose of the study, the 
nature of the study, research questions (RQs) and hypotheses, and the theoretical 
framework for the study are discussed. The definitions of terms, assumptions, the scope 
and delimitations, and limitations, including threats to validity, are then presented. I 
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conclude the chapter by discussing the significance of the study and summarizing key 
points.  
Background 
Saint Lucia is an island state in the Caribbean. The second largest of the 
Windward group of islands in the Lesser Antilles, it is 27 miles (43 km) long and 14 
miles (23 km) wide, with a population of 183,000 (Government of Saint Lucia, 2018). 
The majority (85.3%) of the island’s population is of African descent, followed by 10.8% 
mixed, 2.2% East Indian, and 0.6% Amerindian (Carib) population groups (PAHO, 
2019). The Ministry of Health is responsible for overseeing the health of the population, 
providing finances, issuing regulations, and developing and enforcing public health 
policies (Government of Saint Lucia, 2015). Saint Lucia’s health system offers primary 
care through a network of wellness centers, polyclinics, and secondary- and tertiary-level 
care through public and private hospitals (PAHO, 2019). In the absence of a national 
health insurance scheme, payment for health services is based on a fee-for-service system 
(St. Lucia News online, 2016). Individuals are free to access care in both the public and 
private sectors. Individuals with individual or group health insurance coverage through 
employment benefits obtain assistance in paying for health services. Individuals 
considered pensioners or having welfare or disability status receive medical aid from the 
Ministry of Health. Others assume full financial responsibility due to the lack of 
insurance or failure to fall within groups afforded medical assistance (GIS, 2016). 
There are four hospitals where patients utilize dialysis treatment on the island: 
The Victoria Hospital (respiratory hospital), Owen King European Union Hospital, 
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Tapion Hospital in the north of the island, and St. Jude Hospital in the south (Ministry of 
Health, 2019). In response to the COVID-19 pandemic, Victoria Hospital was recently 
transformed into a Covid hospital and offered dialysis only to admitted patients requiring 
such treatment (Ministry of Health, 2020). Before the transformation, Victoria Hospital 
was a primary acute care 130-bed hospital, equipped with medical, surgical, maternity, 
and pediatric wards; two operating rooms, one intensive care unit; a laboratory; an X-ray 
and ultrasound lab; a pharmacy; a physiotherapy department; and a pathology lab 
(Ministry of Health, 2019; see also Business View Caribbean, 2019). The Owen King 
European Union Hospital is a 120-bed hospital that provides inpatient and outpatient 
services (St. Lucia News online, 2016). It also houses the island’s largest dialysis out-
patient clinic, which opened in January 2018. This dialysis clinic has 17 nurses and one 
nephrologist (Government of Saint Lucia, 2015; Ministry of Health, 2016).  
St. Jude Hospital, managed by a board of directors, is a 110-bed hospital with 
medical, surgical, maternity, and pediatric wards; two operating rooms; a recovery room; 
an intensive care unit; an emergency room; a pharmacy; a laboratory; an X-ray lab; an 
ultrasound lab; a pathology lab; and a physiotherapy department (St. Jude Hospital, 
2019). St. Jude Hospital’s dialysis clinic currently has eight dialysis machines, 11 nurses, 
two attendants, and one secretary. Operating hours are from Sunday to Saturday, and the 
clinic follows a shift system, the first running from 6:45 am to 2 pm and the second, 1 pm 
to 9 pm. This shift system was developed to benefit and accommodate CKD patients who 
are employed (St. Jude Hospital, 2019).   
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Tapion Hospital, situated in the north of the island, is a private 32-bed hospital, 
with two fully equipped operating rooms and a delivery suite, a laboratory for specimen 
testing, and sleep and radiology labs (Tapion Hospital, 2019). It provides specialty 
services such as neurosurgery, internal medicine; general surgery; dermatology; ear, 
nose, and throat; ophthalmology, pediatrics, orthopedics, oncology, obstetrics, and 
gynecology. It is the only hospital with computerized tomography and magnetic 
resonance imaging scanners on the island (Tapion Hospital, 2019). The dialysis clinic at 
Tapion Hospital has been in operation since 1999. According to Nurse Director Connie 
Hager (personal communication, 2019), this private dialysis clinic provides its services to 
local and foreign CKD patients. Patients who are insured or willing to pay out-of-pocket 
can access this service, considering the long waiting lists in the public sector for dialysis 
treatment. Tapion Hospital’s dialysis clinic has eight dialysis stations and five dialysis 
nurses (Draper, 2019). Operating hours are flexible to accommodate patients who are 
employed seven days a week. The government subsidizes the cost of dialysis treatment at 
Tapion Hospital for some patients to address delayed treatment and long waiting lists in 
the public sector (Nurse Connie Hager, personal communication, April 15, 2019).  
Problem Statement 
In recent years, the worsening economy, high unemployment, and the continued 
escalation of health care costs have exacerbated the financial burden for many individuals 
globally (Alphonse, 2017; Tamura et al., 2018). Because employers provide most health 
insurance, loss of employment is frequently accompanied by loss of health insurance and 
the inability to afford health care (Garcia-Garcia & Jha, 2015; Nicoll et al., 2017). Most 
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CKD patients in Saint Lucia are unemployed because of high absenteeism and frequent 
comorbidities (Pan American Health Organization, 2019). The Ministry of Health has 
also reported an alarming increase in the number of patients diagnosed with CKD in both 
the public and private sectors (GIS, 2015; St. Lucia News Online, 2016).  
According to officials from the Ministry of Health, dialysis constitutes a large part 
of the Saint Lucian health care budget, contributing to the increased burden of disease to 
the government. Consequently, hospitals treating CKD patients face challenges in 
providing care in a resource-poor environment (St. Lucia News Online, 2019). The lack 
of resources, including inadequate dialysis machines, long waiting lists, and the high cost 
of medication and dialysis treatment, contribute to the decreased access to care for CKD 
patients (Meade et al., 2018; St. Lucia News Online, 2016). According to the Institute for 
Health Metrics and Evaluation (2016), CKD was ranked as the seventh leading cause of 
death in 2005 and rose to the fifth leading cause of death in 2016 in Saint Lucia. 
Similarly, CKD rose from eighth to sixth place in similar years as the leading cause of 
premature death. Consequently, CKD was the leading cause of death and disability 
combined in 2016 in Saint Lucia (Institute for Health Metrics and Evaluation, 2018), 
making this topic critically important.  
Purpose of the Study 
This quantitative study's primary focus was to utilize secondary data to examine 
whether a relationship exists between dialysis utilization, health insurance, and 
government subsidization for CKD patients in Saint Lucia. I examined the efficacy of the 
government’s subsidization program for dialysis and CKD's baseline characteristics in 
9 
 
Saint Lucia. The study's covariates were age, race, gender, geographical location, CKD 
stage, and attending hospital.  
Research Questions and Hypotheses 
RQ1: Is there a relationship between health insurance and dialysis utilization for 
CKD patients when controlling for age, race, gender, geographical location, employment 
status, CKD stage, CKD cause, and attending hospital in Saint Lucia? 
H01: There is no statistically significant relationship between health insurance and 
dialysis utilization for CKD patients when controlling for age, race, gender, 
geographical location, employment status, CKD stage, CKD cause, and attending 
hospital in Saint. Lucia. 
Ha1: There is a statistically significant relationship between health insurance and 
dialysis utilization for CKD patients when controlling for age, race, gender, 
geographical location, employment status, CKD stage, CKD cause, and attending 
hospital in Saint. Lucia. 
RQ2: Is there a relationship between employment and dialysis utilization for CKD 
patients when controlling for age, race, gender, geographical location, CKD stage, and 
attending hospital in Saint. Lucia? 
H02: There is no statistically significant relationship between employment and 
dialysis utilization for CKD patients when controlling for age, race, gender, 




Ha2: There is a statistically significant relationship between employment and 
dialysis utilization for CKD patients when controlling for age, race, gender, 
geographical location, CKD stage, CKD cause, and attending hospital in Saint. 
Lucia. 
RQ3: Is there a relationship between government subsidization and dialysis 
utilization for CKD patients in Saint Lucia? 
H03: There is no statistically significant relationship between government 
subsidization and dialysis utilization for CKD patients in Saint Lucia. 
Ha3: There is a statistically significant relationship between government 
subsidization and dialysis utilization for CKD patients in Saint Lucia. 
Theoretical Framework 
This study's theoretical framework was grounded in Andersen and Newman's 
(1995) health services utilization framework. This framework is a conceptual model 
aimed at demonstrating the factors that lead to health services usage. This framework’s 
primary premise is that an individual’s access to and use of health services is a direct 
function of three characteristics, including (1) predisposing factors, (2) enabling factors, 
and (3) need factors (Norton & Eggers, 2020). According to Andersen (1995), utilization 
of health services should be examined within the context of (1) Predisposing factors such 
as socio-cultural characteristics that exist before illness, (2) Enabling factors that address 
the logistical aspects of obtaining care, and (3) Need elements generated by functional 
and health problems of an individual.  
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This framework may help to grasp an understanding of why CKD treatment is 
lapsing within the Caribbean. Erickson et al. (2018) used this framework to examine 
enabling factors such as employment among patients utilizing dialysis in the United 
States. In another study, Perez et al. (2018) utilized this framework to test the hypothesis 
that the enabling factor, health insurance, influenced the use of peritoneal dialysis in the 
United States. Soyibo et al. (2011) used this framework to examine healthcare utilization 
trends among CKD and ESRD patients from the Caribbean renal registry. Pallayova et al. 
(2018) used this framework to explore the factors contributing to limited access to 
medical services, specialist care, diagnostic tests, and medications for CKD patients in 
LMICs. This study will examine the relationship between predisposing factors such as 
age and race and enabling factors, such as health insurance, employment, and 
subsidization, on dialysis utilization.  
Nature of the Study 
This study was quantitative and correlational. Data from the Ministry of Health’s 
renal registry database was used in this retrospective cohort study to examine the 
relationship between independent variables; health insurance, employment, and 
subsidization, and CKD patients' dialysis utilization as the dependent variable. The 
relationship between insured/uninsured, employed/unemployed and subsidized and 
unsubsidized, and dialysis utilization are discussed. Other characteristics of the study 
population, such as age, gender, race, CKD stage, geographical location, CKD cause, and 
attending hospital, were examined.  
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Literature Search Strategy 
The search strategy used for this literature review involved electronic research 
databases such as MEDLINE, CINAHL, ScienceDirect, and PubMed. The main 
keywords for this study related to the topic and Boolean operators to find relevant 
literature. The search keywords included chronic kidney disease, dialysis utilization, 
renal disease, CKD in the Caribbean, ESRD in the Caribbean, subsidization, low-to-
middle-income countries, and end-stage-renal disease. Scholarly peer-reviewed journals 
from 2016 to 2020 were included in this study.  The articles' reference list was scanned in 
the literature search to identify additional studies within the publication date range.  
Literature Review Related to Key Variables and Concepts 
This literature review includes studies on health insurance and government 
subsidization programs and their impact on CKD patients' dialysis utilization. The health 
services utilization model was the theoretical framework guiding this study (Norton & 
Eggers, 2020). The effect of this model's components (particularly predisposing factors) 
on dialysis utilization among CKD patients were examined. This literature review 
highlights scholarly literature pertinent to CKD in LMICs, dialysis utilization within the 
CKD population, health insurance impact on dialysis utilization, and subsidization impact 
on Saint Lucia's dialysis utilization. 
Chronic Kidney Disease in Low-to Middle-Income Countries 
Numerous studies dealing with CKD's implications describe the condition as a 
critical public health problem (Jager & Fraser, 2017). Consequently, general population-
based studies, the CKD prognosis consortium, and renal registries worldwide have 
13 
 
contributed to the description of CKD's scale as a significant public health problem 
(Thomas, 2019; George et al., 2017). The burden of CKD is increasing due to higher 
morbidity and mortality, especially in countries, regions, communities, and ethnicities 
with a higher-than-average CKD incidence (Lin et al., 2019; George et al., 2017). 
Pallayova et al. (2018) also supported this fact, stating that an increase in the global 
population and improvements in cardiovascular survival and aging have led to profound 
global epidemiological changes. However, CKD's prevalence, clinical, and economic 
burden has risen worldwide, particularly in LMICs. Although the global burden of CKD 
is primarily due to diabetes and hypertension, current studies purport that other 
contributing factors include limited access to health care, insufficient availability of renal 
replacement therapy, and a shortage of trained personnel (Obrador & Levin, 2019). 
Pallayova et al. (2018) found that LMICs have the fastest CKD growth due to limited 
access to medical services, such as dialysis treatment, specialist care, diagnostic tests, and 
medication. Osman et al. (2019) also suggest that LMICs have a more significant burden 
in managing CKD due to limited programs and surveillance systems.  
The global disease burden of CKD was assessed in a recent report evaluating the 
2017 Global Burden of Disease Study results. This study revealed that certain world 
regions, such as the Caribbean, reported higher CKD rates than other developed world 
regions, decreasing prevalence and mortality (Thomas, 2019). Stanifer et al. (2016) argue 
that countries that adopted the World Health Organization (WHO) 2015 people-centered 
health services framework contributed to CKD management improvements. The people-
centered health services framework, especially for the CKD population, emphasizes 
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health care that “adopts individuals, carers, families, and communities into trusted health 
systems” (Morton & Sellars, 2019). This adoption also sparked a movement among 
international policymakers, service providers, and professional disciplines to strive 
toward providing, at a reduced cost, all elements along the continuum of care for CKD 
patients. Conversely, countries that failed to adopt this framework purported to struggle 
significantly with improvement initiatives in addressing CKD's critical issue in the 21st 
century.  
Saint Lucia has made progress toward the adoption of the WHO’s 2017 person-
centered framework. However, due to heavy reliance on international funding for health 
care, CKD initiatives fall short of meeting the increasing demands (GIS, 2016; Ministry 
of Health, 2019). Studies have shown that LMICs have a fragmented health system, and 
CKD is not a significant priority (Crews et al., 2017; Hill et al., 2016; National Institute 
of Diabetes and Digestive and Kidney Disease, 2019). Additionally, Stanifer et al. (2016) 
purport that factors such as lack of data, few studies, variable quality in reporting, and 
inconsistent methods for assessing and defining kidney dysfunction contribute 
significantly to discovering accurate trends of CKD in LMICs.  
Management of Chronic Kidney Disease in Saint Lucia 
A significant number of patients suffer from CKD in Saint Lucia. In Saint Lucia, 
CKD patients access dialysis treatment from either the public or the private sectors. 
According to Chief Nephrologist Dr. Merle Clarke, treatment is costly, particularly for 
patients at stage five requiring dialysis or a renal transplant (Ministry of Health, 2019). 
CKD patients can obtain an unofficial diagnosis from any of the island's wellness centers, 
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polyclinics, or hospitals. However, a nephrologist officially diagnoses patients with CKD 
and determines a treatment plan. If dialysis is required, patients are free to access dialysis 
at any of the public or private clinics (Government of Saint Lucia, 2018). Upon official 
diagnosis, patients' data is entered into the renal registry database (Ministry of Health, 
2019).  
The CKD numbers are rising each year in St. Lucia. In 2015, 101 patients were on 
dialysis at Victoria Hospital and St. Jude Hospital, with a waiting list of 86 patients 
(Government of Saint Lucia, 2015; Ministry of Health, 2019). Data further indicated that 
among those documented with ESKD, 172 had progressed to stage three and 150 to stage 
four (Caribbean Renal Registry, 2018). For the average patient, dialysis treatment is out 
of reach without massive government subsidization of health insurance coverage 
subsidies. Dialysis subsidization does not include medication cost, which remains the 
patient's sole responsibility (GIS, 2015). As CKD's prevalence and incidence continue to 
rise, Saint Lucia's government turns to other countries, organizations, or financial 
institutions to assist in purchasing additional dialysis machines or covering patients' 
treatment through the established subsidization program (GIS, 2015).  
Dialysis Utilization 
Survival for individuals living with CKD depends on either a kidney transplant or 
renal replacement therapy (RRT) to substitute failed kidney function (Draper, 2019). 
Kidney transplantation is the transplant of a kidney into a patient with ESRD. 
Hemodialysis is the substitution of the kidneys function by a specialized machine called a 
dialyzer to purify the blood (Thomas, 2019). RRT is not available in all Caribbean 
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countries, and where available, the most common modality is Hemodialysis [HD] (Meade 
et al., 2018). Liyanage et al. (2015), in a study examining universal access to dialysis 
treatment for CKD, found that in 2010, 2.618 million people received RRT. An estimated 
4.902 million were reported in need of dialysis, and 2.284 million were estimated in their 
conservative model to be prone to premature death due to having no access to treatment 
(Liyanage et al., 2015; Luyckx et al., 2018). The rate of patients receiving dialysis is 
growing at an annual global average rate of 7%, due in part to the universal aging of 
populations (Mushi et al., 2015). Despite the high estimates (2 million) of CKD patients 
receiving dialysis in 2010, that figure was predicted to double by 2030 (Luyckx et al., 
2017). CKD/ESRD was reported to be at an alarming growth rate of 1.3%, five times the 
world’s population growth (Thomas, 2019). In 2008, approximately 1.75 million patients 
worldwide received regular renal replacement therapy in the form of dialysis. 1.55 
million or 89% were on hemodialysis (HD), and about 197,000 (11%) were on peritoneal 
dialysis (PD). Interestingly, 62% of CKD patients were treated in LMICs.  
 Since 2013, the federal government assumed some or all financial responsibility 
for services rendered to nearly 450,000 Americans on dialysis (United States Renal Data 
System [USRDS], 2015). More recently, the CDC (2019) reported an estimated 37 
million American adults diagnosed with CKD. Wu et al. (2017) assessed CKD care 
quality and its association with long-term dialysis, acute kidney injury (AKI), and death. 
A retrospective cohort study of 63, 260 adults with incident CKD, were enrolled in a 
Longitudinal Cohort of Diabetes study. Their findings revealed 1,471 patients 
commenced long-term dialysis treatment, 2,739 patients were hospitalized due to AKI, 
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and 4,407 patients in the study died. Consequently, higher overall quality scores for CKD 
patients were associated with lower hazard long-term dialysis treatment (Mushi et al., 
2015). Despite the quality outcomes of dialysis, Lin et al. (2019) purported that CKD 
patients had higher healthcare utilization rates, morbidity, and mortality in a study that 
examined the relationship between maintenance HD and emergency utilization.  
 Shaikh et al. (2018) also substantiated this claim in a study assessing utilization, 
costs, and outcomes for patients receiving publicly funded HD. Moreover, their research 
revealed that India's number of dialysis centers increased from 50 in 2008-2009 to 89 in 
2011-2012. There was an estimated 29.5 percent of the population on HD in 2008 and 
69.8 percent of the population in 2012. This study suggested that CKD patients absorbed 
a more substantial healthcare services portion, mainly because the health system cannot 
meet dialysis demands. The number of dialysis units for every 100 patients with CKD 
was 0 to 1.89 across all districts in Andhra Pradesh, India, and that there was one dialysis 
unit for every 100 CKD patients. Like India, Saint Lucia is considered a developing 
country or an LMIC with similar constraints and limited resources. Another study 
investigated dialysis provision and the implications of health economics in Malaysia. 
Studies also purport that inequality in access to dialysis exists within geographical 
locations in LMICs (Andersen, 2018; Mohd et al., 2017; George, Mogueo, Okpechi, 
Echouffo-Tcheugui & Kengne, 2017).  
Mohd et al. (2017) found that CKD's prevalence increased from 504 per million 
in 2005 to 1155 per million in 2014. An estimated 1046 patients were on HD and 109 on 
PD in 2014. This study also revealed inequality in access to dialysis within geographical 
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regions in Malaysia, despite government funding. From these studies, it is evident that 
CKD's prevalence and incidence continue to rise, especially among LMICs. Additionally, 
LMICs continue to struggle with meeting the health demands of CKD patients in need of 
RRT, such as HD (George et al., 2017). 
Costs of Dialysis Treatment 
According to Li et al. (2019), CKD and dialysis are medical and economic 
problems. RRT consumes many resources as equipment and materials are expensive 
(Mohd et al., 2017; Hill et al., 2016; Kramer et al., 2018). Consequently, dialysis requires 
qualified personnel. Cost is defined as “the monetary value of the resource consumption 
for producing a commodity or service, frequently expressed as a composite sum of 
quantities of some activity multiplied by their respective prices” (Mushi et al., 2015). 
There are four cost categories: “direct medical costs, direct non-medical costs, indirect 
costs, and intangible costs” (p.160). Direct medical costs of dialysis include “staffing 
costs, physician fees or salary, cost of dialyzers and tubing in hemodialysis, the cost 
associated with radiology, laboratory and medications, capital costs of HD machines, 
costs of hospitalizations and costs of out-patient consultations from other specialists 
(Mushi et al., 2015). Direct non-medical costs include building costs, facility utilities, and 
other overhead costs. Intangible costs are costs associated with pain, suffering, and 
impairment in quality of life”(p.162). In the Caribbean region, most, if not all, countries 
cannot sustain the financial burden of CKD. Shechter et al. (2017) investigated the timing 
of vascular access (VA) referral for patients with CKD in need of hemodialysis (HD), 
concerning age and costs. This study revealed that the cost-effectiveness of VA referral 
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was primarily driven by HD's annual expenses, erythropoietin costs, and access-specific 
utilities.  
The increasing number of dialysis units through-out the English-speaking 
Caribbean has doubled between 2006 and 2011, placing an increased financial strain on 
these governments and health systems. However, issues such as limited personnel in 
managing these units, lack of financial resources, and support from both the government 
and private sector continue to affect the availability of these treatments in the Caribbean. 
Saint Lucia continues to battle the increasing numbers of CKD patients needing RRT, 
and as such, has expanded the public dialysis clinic’s capacity to accommodate more 
patients (GIS, 2015). According to the Ministry of Health, the primary barrier to CKD 
management's improvement efforts is the economic constraints (Government of Saint 
Lucia, 2015). Saint Lucia has adopted a public-private financing model for HD, where 
patients receive funding for treatment at both public and private clinics. Dr. Merle Clarke 
(2019) stated that the allocation of healthcare funds in the budget falls short of meeting 
the growing demand for HD, personnel, and unit maintenance. Moreover, she lamented 
that CKD's poor management in a resourced poor healthcare system was consequential to 
the limited funding (Ministry of Health, 2019).  
In the English-speaking Caribbean and other LMICs, healthcare has become one 
of the most significant financial burdens on the government (Jager & Fraser, 2017). The 
government adopted various models of care, improvement initiatives, and subsidization 
programs to address this burden. For example, Malaysia, an LMIC, established an HD 
subsidization program in 2008 to provide treatment to CKD patients. Like Saint Lucia, 
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the government adopted a public-private financing model to cover HD's cost through a 
national insurance scheme (Mohd et al., 2017). Dialysis costs in Barbados were 
approximately USD 156.64 per treatment in the first year and USD 145.55 in subsequent 
years (Labonté et al., 2017). A total cost per patient per year of USD 18,327.22 in the 
first year of HD was found, including surgical setup, and USD 17,029.54 for subsequent 
years and the direct costs of HD contributed overall was 80.7% (Caribbean Renal 
Registry, 2018). These findings presented data that sparked health officials' attention and 
encouraged CKD patients' development funding programs.  
Employment and Dialysis Utilization  
Employment for CKD patients on dialysis has recently become an essential 
outcome in kidney management (Liyanage et al., 2015; CDC, 2019; Draper, 2019). Long-
term dialysis therapy takes a heavy toll on the quality of life for CKD patients. Fatigue, 
decreased physical capability, impaired social and mental functioning all contribute to 
this forlorn state. CKD patients experience tremendous difficulty maintaining dialysis 
treatment while keeping regular employment (Erickson et al., 2018; Luyckx et al., 2017). 
Lakshmi (2017), in a cross-sectional study of employment and dialysis utilization in 
South India, found that patients' employment status before dialysis was 60% (93 out of 
155) for patients receiving HD. The study revealed that 44% (41 out of 93) experienced a 
loss of employment status after initiation. Chironda and Bhengu (2019) also agreed that 
long-term dialysis affected employment status. Another study explored barriers to CKD 
management in renal clinics in KwaZulu – Natal Province, South Africa. The researchers 
examined the side effects of treatment, the longevity of hemodialysis treatment, lack of 
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employment opportunities resulting from CKD, and health insurance coverage.  All 
barriers to the management of CKD. Despite current measures by state hospitals to 
provide CKD management, barriers to the management of CKD still exist.  
Harris (2017) examined the issue of ESKD in a study that included 92 participants 
from around the globe, including 16 participants from 11 LMICs. This study found that 
LMIC countries were severely affected by the lack of resources and finances to manage 
CKD, particularly with a loss of employment for long-term dialysis patients. The study 
further purported that LMICs would benefit from improved workforce training, equitable, 
efficient, and cost-effective funding models, among others, in the management of CKD. 
Coming a little closer to home, Meade et al. (2018) examined the causes of CKD and its 
association with high morbidity and mortality at two hospitals in Antigua. A retrospective 
review of CKD patients' medical records diagnosed between January 1, 2005, and 
December 1, 2013, was performed. The results revealed that CKD causes were diabetes 
mellitus, hypertension, glomerulonephritis, and lupus nephritis. 
Consequently, most of the CKD patients in the study faced difficulty keeping 
employment, and thus, the financial burden fell upon their families and the government. 
Early recognition and aggressive CKD management significantly reduced the clinical and 
economic burden (Meade et al., 2018). In Saint Lucia, most CKD patients are 
unemployed and reliant on their families and the government for financial assistance 
(Government Information System, 2015; Ministry of Health, 2019). Furthermore, HD and 
the medications usually prescribed to CKD patients are not affordable for the average 
patient. Dialysis is an intensive and time-consuming treatment. Patients on dialysis may 
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have other medical problems, including cardiovascular disease, diabetes, bone disorders, 
anemia, visual impairment, malnutrition, depression, and cognition changes. These 
factors are often associated with job loss (Jager & Fraser, 2017).  
The Ministry of Health embarked on numerous initiatives, especially at the 
primary level, to curb CKD's growing prevalence in Saint Lucia (GIS, 2016). The 
negative consequences of CKD are evident at both the social and economic levels. 
Improvement efforts in CKD management resulted in expanding dialysis accessibility 
(Government of Saint Lucia, 2018). Okpechi, Bello, Ameh, and Swanepoel (2017) 
examined appropriate approaches to manage CKD in LMICs. Their study revealed that 
workforce deficiencies, infrastructure, cost of treatment, lack of proper systems approach 
policies were barriers to effective CKD care delivery in LMICs. Additionally, they 
concluded that the adoption of WHO proposed Innovative Care for Chronic Conditions 
(ICCC) was presented as a suitable health system model to help manage CKD's 
increasing incidence in LMICs.  
Health Insurance, Subsidization, and Dialysis Utilization 
According to Luyckx et al. (2017), access to dialysis remains highly inequitable in 
LMICs despite dialysis facilities' existence. To address CKD's growing prevalence and its 
financial impact on Saint Lucia, the government launched a dialysis subsidization 
program in 1999 (Government Information System, 2016; Ministry of Health, 2019). 
Consequently, this subsidization program helps cover some of the cost of care for patients 
with no medical insurance coverage, unemployed, or disabled due to CKD (Ministry of 
Health, 2019). Like Saint Lucia, many countries take the lead from the United States, 
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where the government intervenes in providing support for vulnerable patients on dialysis 
(Ajmal et al., 2019). Some individuals purchase private health insurance covering some, 
if not all, of their dialysis treatments, labs, and medications. However, this is not the 
norm, as most CKD patients obtain health insurance coverage through their employment 
(GIS, 2016). Saint Lucia is far from reaching the financial support level that countries 
like the United States make toward CKD management (Caribbean Renal Registry, 2018). 
In 1972, the United States Congress established Medicare coverage for ESRD patients, 
despite age or high treatment costs (USRDS, 2015). These initiatives have contributed 
significantly to the improvement of the management of CKD. According to Andersen 
(2018), the impact of Medicare's expansion among individuals with CKD has increased 
coverage by 30% and increased doctor visits by 35%. 
Additionally, this expansion decreased mortality due to CKD in the under 65 
population between 0.5, 50, 1.0 deaths per 100,000 (Andersen, 2018). Perez et al. (2018) 
examined the effect of health insurance on dialysis utilization using a retrospective cohort 
analysis of patients with similar socioeconomic status, and limited insurance coverage 
was included in the study. This study found that patients with limited insurance had an 
absolute lower probability of dialysis use. Ajmal et al. (2019) corroborated these findings 
and found that improvement initiatives by the Centers for Medicare and Medicaid 
Services (CMS) revealed improved outcomes for CKD patients. Many countries are 
adopting programs that improve access to care for CKD patients. Before 2016, CKD was 
managed locally by internal medicine physicians. Since then, the island now has two 
nephrologists (GIS, 2016). For example, through the Department of Medicine’s rigorous 
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efforts at the University of the West Indies, Jamaica has nine adult and two pediatric 
nephrologists (Horspool, 2018). The Caribbean Institute of Nephrology (2018), aside 
from conducting programs and forums to educate the public, also extend training to 
health professionals in neighboring islands. Many Caribbean countries subsidize a large 
extent of health care for CKD patients (Caribbean Renal Registry, 2018; George et al., 
2017). Tourism generates an extensive amount of revenue for Caribbean Countries. 
Countries like Barbados, Jamaica, Cayman Islands, Trinidad, Tobago, and Saint Lucia 
offer dialysis for tourists traveling. Dialysis availability and accessibility are essential 
factors in the sustainability of the tourism industry.  
According to Dr. Merle Clarke, government subsidization does not cover all the 
costs associated with CKD patients' health expenses. Patients assume responsibility for 
out-of-pocket costs, including weekly dialysis treatments, not subsidized, laboratory 
testing, and medication. Patients can receive coverage for dialysis through the 
subsidization program, anywhere from one to three treatment sessions a week. 
Additionally, for patients who have no health insurance coverage or are not recipients of 
a subsidization program, dialysis becomes tremendously inaccessible (Luyckx et al., 
2017). Krishnan (2019) argues that government subsidization provides a substantial 
benefit to CKD patients who have limited income and must cover part of treatment costs 
and other ancillary expenses, such as transportation to and from treatments and 
medications. Jager and Fraser (2017) purport that in countries like India, where much of 
the payment for dialysis is out-of-pocket, subsidies could significantly impact CKD 
patients. There are substantial differences in how various governments provide and 
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subsidize disability and unemployment benefits to those affected by CKD. As the world’s 
population increases, so will societal demands for health equity. Morton and Sellars 
(2019) suggest that balancing societal and personal costs for CKD will be a continuous 
learning curve for policymakers, health leaders, communities, families, and patients.  
This literature review presents the global trends, management, costs, employment, 
subsidization, and dialysis utilization for CKD in the Caribbean and other LMICs. 
Definitions 
Chronic kidney disease (CKD): A progressive loss of renal function that lasts for 
more than three months and is classified according to the degree of kidney damage 
measured by the level of proteinuria and the decline in glomerular filtration rate (GFR; 
NKF, 2019).  
Dialysis: The clinical purification of blood as a substitute for the normal function 
of the kidney. The two main types of dialysis are peritoneal dialysis and hemodialysis. 
Peritoneal dialysis entails placing a soft, hollow tube into the lower abdomen near the 
navel and a particular dialysate solution into the peritoneal cavity (Draper, 2019). The 
dialysate left in the stomach for a period absorbs waste products and toxins through the 
peritoneum. Fluid drained from the abdomen is measured and discarded (Vadakedath & 
Kandi, 2017). Hemodialysis is a procedure where a dialysis machine and a special filter 
called an artificial kidney, or a dialyzer, are used to clean the blood. The process entails 
an arteriovenous fistula access in the arm, and the joining of an artery and a vein for 
blood purification (National Kidney Foundation, 2019). As shown in Figure 2, a 
hemodialysis machine connected to the arteriovenous access in the arm of a patient drains 
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the blood and bathes it in a particular dialysate solution to remove waste substances, 
fluid, and toxins, and then returns it into the bloodstream (National Institute of Diabetes 
and Digestive and Kidney Diseases, 2019).  
Dialysis utilization: The measure of CKD patients’ use of dialysis treatment to 
manage their condition. 
 
Figure 2 
Diagrammatic Representation of a Dialyzer  
 
Note. This figure presents a diagrammatic representation of a dialyzer, depicting the 
dialysis process. From Hemodialysis, by the National Institute of Diabetes and Digestive 
and Kidney Disease, 2018 (https://www.niddk.nih.gov/health-information/kidney-
disease/kidney-failure/hemodialysis). In the public domain. 
 
Employment: The relationship between the employer and employee based on a 
contractual agreement for paid work. 
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End-stage renal disease: An irreversible decline in a person’s kidney function that 
is severe enough to be fatal in the absence of dialysis or kidney transplantation (Benjamin 
& Lappin, 2020). 
Health care utilization: The quantification or description of the use of services by 
persons to prevent and cure health problems, maintain health and well-being, or obtain 
information about one's health status and prognosis (Encyclopedia of Behavioral 
Medicine, 2019).  
Health insurance: Coverage that provides payments of benefits in whole or in part 
for an individual's risk of incurring medical expenses (Perez et al., 2018). 
Kidney transplant: A healthy kidney's surgical placement into the body from a 
deceased donor or a close living relative. A kidney transplant is a treatment, not a cure, 
and requires antirejection and other medications to maintain the transplant (NKF, 2019).  
Ministry of Health: The government body set up by the central government of Saint Lucia 
and mandated with the health sector's stewardship and leadership. This ministry is responsible for 
providing “quality care to individuals, families, and communities regardless of race, religion, 
socioeconomic status or political affiliation” (Ministry of Health, 2019, Mission section). 
Pan American Health Organization (PAHO): An entity that proclaims itself as “the 
world’s oldest international public health agency” and which engages in “strategic collaborative 
efforts among the Member States and other partners to promote equity in health, to combat 
disease, and to improve quality of life of the peoples of the Americas” (PAHO, 2017, para. 1). 
Renal replacement therapy (RRT): Therapy that replaces the normal blood-
filtering function of the kidneys due to kidney failure; it includes hemodialysis, peritoneal 
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dialysis, and kidney transplantation, which is the ultimate form of replacement of the old 
kidneys (National Institute of Diabetes and Digestive and Kidney Disease , 2019).  
Assumptions 
There were several assumptions for this study. The first assumption was that the 
existing National Renal Registry cohort data contains accurate and reliable information. 
This assumption was essential because retrospective cohort data may involve selection 
bias and misclassification bias (Back & Kelly, 2019). An examination of patients with 
CKD who accessed dialysis treatment from 2015 to 2019 in Saint Lucia was carried out 
to limit misclassification bias.  Cohort data from the national renal registry of the 
Ministry of Health, central statistics office, was used in this study.  The central statistics 
office is responsible for internal automated and external quality control scrutiny to ensure 
that databases are accurate and beneficial to researchers, practitioners, and policymakers.  
The second assumption was that the existing database would contain all the 
variables needed for this study. Heinze et al. (2018) highly recommend that researchers 
use variables from the same dataset to avoid reliability issues. The third assumption was 
that the data set variables would be valid and appropriate for measuring the conceptual 
framework domains. Shang et al. (2018) purported that data suitability and quality are 
essential to a successful study. Furthermore, they suggest that a dataset's fitness is 
determined by the extent to which it meets the research purpose or needs. Finally, the 
assumption that the simple random sampling procedure is accurate and truthful eliminates 
potential internal and external validity threats. According to Back and Kelly (2019), 
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stratified random sampling allows the opportunity to obtain a sample population that best 
represents the entire population studied.  
Scope and Delimitations 
To answer the RQs and address the research gap, this study was delimited to a 
national sample of CKD patients who accessed dialysis for five years from 2015 to 2019. 
Additionally, it was delimited to only hemodialysis utilization. All other forms of RRTs 
were excluded. Therefore, the sample selected may not represent all patients in the 
national CKD population who utilized dialysis and received government subsidies. Due 
to this delimitation, the study's findings had limited external validity and were not 
generalizable to other CKD patients outside Saint Lucia.  
A significant strength of this study was the use of a National Dataset. Access to 
this dataset provided the opportunity to use CKD information, dialysis utilization, and 
sufficient numbers of males and females in the CKD population for meaningful analysis. 
According to Frankfort-Nachmias (2018), national datasets are seen as the intellectual 
output of research and prove beneficial for longitudinal or retrospective studies.   
Limitations 
One limitation of this study was generalizability. This study's findings could not 
be generalized to the entire CKD population in Saint Lucia because it was limited to only 
those who accessed hemodialysis from 2015 to 2019. Excluded from this study were 
CKD patients who received other RRTs, were non-national (visitor), or accessed 
hemodialysis outside this period. Additionally, due to demographic differences in the 
30 
 
study’s population, the findings may not be generalized to other CKD populations of 
LMICs.  
A second limitation of this study was the reliance on self-reported information, 
which may be subject to misclassification, selection, and reporting bias. Data was 
crossed-checked and compared with administrative data from the chief nephrologist or 
dialysis clinics to address this limitation. A third limitation was that medical costs due to 
comorbidities were not included in this study's primary or sensitivity analysis. 
Significance 
This study's quantitative findings may provide insight into the financial barriers 
that affect dialysis utilization and, by extension, the management of CKD patients in 
Saint Lucia. This project was unique because it was the first to examine this specific 
population and address a non-communicable disease that had not been thoroughly 
examined in Saint Lucia before. It may add to the limited research on CKD management 
related to health delivery (Tamura et al., 2018) in LMICs. Additionally, this study may 
inform government health officials, policy makers, and healthcare leaders of the efficacy 
of the dialysis subsidization program for CKD patients in Saint Lucia.  
This study may lead to a greater understanding of how access to dialysis treatment 
has improved due to government subsidization. Information from this study may 
contribute to health service delivery improvement initiatives and motivate policies that 
may remedy financial barriers and improve access and quality of care for CKD patients in 
Saint Lucia (Wilk et al., 2019). Consequently, the findings may provide information 
about CKD trends, financial barriers to access care for CKD patients, and 
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recommendations for policy or social change improvement initiatives. Furthermore, the 
proposed study was essentially a policy analysis of the government subsidization 
program efficacy and, therefore, potential societal relevance. If the findings reveal that 
government subsidization is positively impacting dialysis utilization, then the policy 
works. If it does not, this provides evidence that the policy should be revised. 
Summary and Conclusions 
CKD is considered a progressive disease in patients with hypertension and 
diabetes that efficient primary care interventions can help (NIH, 2014). Implementing 
health initiatives at the local level, such as subsidizing anti-hypertensive and diabetic 
medications, facilitating lifestyle and lipid modification programs, and equipping 
wellness centers and polyclinics with the necessary human resource is essential (Business 
View Caribbean, 2019; National Institute of Diabetes and Digestive and Kidney Disease, 
2019; Nicoll et al., 2017). Implementing measures to decrease the number of patients 
who develop CKD may reduce the demands for more resources (Caribbean Renal 
Registry, 2018).  
Current research suggests that as the global population increases annually, so will 
the number of patients who develop CKD (Jager & Fraser, 2017; Morton & Sellars, 2019; 
Business View Caribbean, 2019). Investment in more equipment and health professionals 
specialized in this area is essential but may not be sustainable, particularly in LMICs 
where patients lack the financial resources to manage CKD (Erickson et al., 2018). 
LMICs could glean from implementing government programs such as the Affordable 
Care Act of 2010, which provided coverage for many uninsured CKD patients who 
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needed critical care access. Making CKD a significant health priority by implementing 
subsidy programs or strengthening existing ones may help alleviate its current financial 
burden (Draper, 2019; Tamura et al., 2018; Anderson, 2018).  
Although the CDC (2018) has stated that CKD is a global health problem, the 
International Society of Nephrology (2019) further purports that CKD's prevalence and 
its complications vary widely worldwide. Socha (2019) concluded that a patient’s health 
insurance status affects dialysis utilization and modality choice after conducting a 
retrospective cohort analysis to examine whether peritoneal dialysis was affected by 
health insurance status. According to a report from the USRDS (2018), dialysis 
utilization for new patients was recorded at an increased 80% due in part to Medicare 
coverage and improved health awareness. A study that examined the effect of universal 
insurance coverage on access to care for CKD patients, Harris and Davies (2019), 
purported that inequities, as shown in Figure 3, were evident in dialysis utilization CKD 
implementation of universal health coverage in LMICs. Additionally, they found that 
dialysis utilization varied in different regions of the same country and between urban and 
rural areas.  
Stanifer et al. (2016) argue that priority is low in the public health response to 
CKD among LMICs. Consequently, making CKD a priority could lead to social change 
in CKD management and the reversal of its high ranking as a cause of death and 




Prevalence and Incidence Rates of End-Stage Renal Disease 
 
Note. This figure presents the (a) Prevalence and (b) incidence rates of end-stage kidney 
disease (ESKD) (treated), dialysis, hemodialysis, peritoneal dialysis, kidney 
transplantation (Tx), and donor type in high-income countries versus non-high-income 





Section 2: Research Design and Data Collection 
Introduction 
The purpose of this quantitative study was to examine the relationship between 
health insurance, employment, subsidization, and dialysis utilization among CKD 
patients in Saint Lucia. Although there have been numerous studies on dialysis 
utilization's financial barriers, few researchers have examined the efficacy of government 
subsidization for dialysis utilization in LMICs (Caribbean Renal Registry, 2018; Erickson 
et al., 2018; Li et al., 2019). Consequently, policymakers, healthcare officials, and other 
stakeholders may obtain information that can impact CKD’s future payment models and 
disease management in Saint Lucia. In this section, I discuss the research and design 
rationale, methodology, and threats to validity.  
Research and Design Rationale 
The quantitative causal-comparative research design was used in this doctoral 
study to investigate group populations. I compared same subjects (individuals diagnosed 
with CKD) across the period 2015–2019, using a single data set with information on 
dialysis treatment at any of the dialysis clinics on the island (Owen King European Union 
Hospital, Victoria Hospital, St. Jude Hospital, and Tapion Hospital). The dependent 
variable in the study was dialysis utilization. The independent variables were 
subsidization, employment, and health insurance. Covariates included age, gender, race, 
geographical location, CKD stage, CKD cause, and attending hospital. Secondary data 
for this study were obtained from the Ministry of Health’s Central Statistics Office, 
which is responsible for the collection, compilation, analysis, and dissemination of 
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statistical information in Saint Lucia (Government of Saint Lucia, 2018). In this way, the 
data were obtained in a manner that was feasible and accessible (Frankfort-Nachmias, 
2018). Raw data from the various dialysis clinics on the island are submitted central 
statistics office through the Ministry of Health for further analysis. Specifically, I 
obtained data for the study from the renal registry, which records data for all CKD 
patients accessing dialysis treatment in both the public and private sectors. The renal 
registry was developed in response to the need of health officials, policy makers, and 
health care providers to understand the prevalence of CKD and why it has become the 
number one cause of death and disability combined in Saint Lucia (Caribbean Renal 
Registry, 2018). This study may help bridge the gap and provide necessary information 
for social change, including insight into the dialysis subsidization program's efficacy.   
Specifically, I analyzed a retrospective CKD cohort using data from three dialysis 
clinics in Saint Lucia that accessed care between 2015 and 2019. The quantitative causal-
comparative design was chosen for four reasons. First, the quantitative methodology is 
employed when the goal is to measure variables numerically using commonly accepted 
measures of the physical world (Creswell, 2018; Hair et al., 2018; Leedy & Omrod, 
2018). Second, the quantitative methodology is used when RQs are examined through the 
statistical examination of data (Creswell & Creswell, 2018). Third, the quantitative 
methodology is employed when the goal of the research is to generalize the findings to a 
larger population from which the study sample is derived (Creswell, 2018; Hair et al., 
2018; Leedy & Omrod, 2018). Fourth, a quantitative study involves using a relatively 
large sample size, which allows for the projection of results to the target population 
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(Creswell & Creswell, 2018). The use of retrospective data helps researchers to determine 
trends in health service utilization (Creswell & Creswell, 2018). Strengths of 
retrospective cohort studies include maintaining a sequence of events and exploring 
several outcomes, such as developing a disease over some time and risk factors of an 
illness and other factors associated with disease outcomes (Creswell & Creswell, 2018; 
Hsu et al., 2019).  
I chose this study's design to address the gaps in research. A comparative analysis 
allowed for examining the relationship between government subsidization, employment 
status, and health insurance in dialysis utilization trends. Use of this research design may 
advance health knowledge on the efficacy of health subsidization programs and health 
insurance's impact on disease management. It may also guide policy makers and 
stakeholders in selecting the best approaches in developing payment models and 




The target population comprised males and females 18 years of age and older 
diagnosed with CKD in Saint Lucia and accessed dialysis treatment between 2015-2019. 
Additionally, the target population included patients within the race categories of African 
Descent, East Indian, or Mixed. The estimated sample size was approximately 979 CKD 
patients registered in the national renal registry from 2015 to 2019. The target population 
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was limited to St. Lucian residents accessing dialysis at any of the four clinics located on 
the island.  
Sampling and Sampling Procedures 
For this study, the data analyzed were secondary data modified based on the 
inclusion and exclusion criteria outlined in this section. The sampling procedures 
involved collecting and organizing secondary data from the renal registry (Caribbean 
Renal Registry, 2018; Government of Saint Lucia, 2018). The sampling process included 
analyzing the patients diagnosed with CKD and examining the renal registry's total 
population. I selected applicable data using simple random sampling.  
After examining the data’s characteristics, it became clearer that simple random 
sampling was a more appropriate sampling methodology, given that all patients in the 
renal registry satisfied essential variables such as age, gender, and the like. According to 
Depersio (2018), “simple random sampling is a method used to pull a smaller sample 
from a larger population and use it to research and make generalizations about the larger 
group” (p.124 ). The use of a simple random sample also allows for an equal probability 
of selecting each unit within a group (Creswell & Creswell, 2018). By using specific 
procedures, I examined dialysis utilization among CKD patients and compared usage 
across payment methods. Additionally, logistic regression was applied to control for 
covariates and compare independent variables. This study's data included descriptive 
statistics using categorical data to measure and compare with crosstabulations, chi-square 




Sample Size and Power Analysis 
At the time of the study, 1,250 individuals were enrolled in the Central Statistics 
Office’s renal registry. I further stratified this sample by using a proportional 
stratification process that included using simple random stratum selection. To calculate 
this study's effect size, I used both chi-square analysis and correlation analysis to measure 
the effect size between groups. Using multiple methods allowed for comparisons of 
dialysis utilization among the CKD population based on three factors: health insurance, 
subsidization, and employment (see Faul et al., 2008). Power analysis for a linear 
regression was conducted in G*Power to determine a sufficient sample size using an 
alpha of 0.05, a power of 0.80, and a small effect size (f2 = 0.02) (Creswell & Creswell, 
2018). Based on the assumptions, the desired sample size was 979. Lakens et al. (2018) 
suggested that researchers may anchor their power analysis on the smallest effect size 
with clear benchmarks if reluctant to rely on the literature. 
Instrumentation and Operationalization of Constructs 
Before data collection, I obtained Institutional Review Board (IRB) approval from 
Walden University and the local site, the Ministry of Health. The Ministry of Health 
approval was a two-step process, requiring permission from the Research Ethical 
Committee (REC) of the Medical and Dental Council, and the Medical Directors of the 
various hospitals. IRB approval was needed to obtain data use agreements approved for 
data collection and analysis. This study posed minimal risk, primarily because it included 
data from an existing cohort with no identifiers and secondary. The data file contained no 
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personally identifiable information. Therefore, there was no concern for violations of 
confidentiality. 
Operationalization 
Across the three RQs, there were three independent variables, employment, health 
insurance, and subsidization, and one dependent variable, dialysis utilization. RQ1 asked, 
Is there any relationship between health insurance and dialysis utilization for CKD 
patients when controlling for age, race, gender, geographical location, CKD stage, and 
attending hospital in Saint. Lucia. For this study, health insurance referred to any form of 
insurance coverage covering dialysis treatment costs. The independent variable health 
insurance was described as a binary variable (yes/no).  
RQ2 asked, Is there any relationship between employment and dialysis utilization 
for CKD patients, when controlling for age, race, gender, geographical location, CKD 
stage, and attending hospital in Saint. Lucia? Employment was defined as any form of 
paid work in which a CKD patient is actively involved. The independent variable 
employment was described as a binary variable (yes/no). RQ3 asked, Is there any 
relationship between government subsidization and dialysis utilization for CKD patients 
in Saint Lucia? For this study, subsidization was defined as a benefit given by the 
government to CKD patients, resulting in reduced dialysis treatment costs to help reduce 
the economic burden on these patients. Independent variable subsidization is described as 




Dialysis utilization will be described as a binary variable due to the utilization of 
logistic regression analysis for this study and assessed by the long-term rate of dialysis 
treatments a CKD patient received. In the binary coding process, dialysis utilization was 
coded as, “1” for yes utilization, and “0” for no utilization. This study focuses on 
hemodialysis because it is the only type of dialysis provided to and utilized by CKD 
patients in Saint Lucia.  
Data Analysis Plan 
The data analysis process consisted of three phases, the data preparation phase, 
the preliminary analysis phase, and the primary analysis phase. The data preparation 
phase comprised the data imputation into SPSS v26 (IBM SPSS Statistics, 2019). After 
that, frequency descriptive statistics were performed to evaluate any missing data or data 
errors. Data errors found were fixed and kept for analysis. Data errors that could not be 
fixed were removed from the data file and were not included in the study. The same was 
done for missing values. Data errors and missing values were minimal in this study. After 
the data was checked for errors and missing values, new variables or variable recoding 
was completed at this point. The preparation phase was completed when all the data had 
been recorded. 
The next phase was the preliminary phase. During this phase, the tests of 
parametric assumptions were conducted. A multiple logistic regression analysis was 
conducted to predict a correlation between independent variables, medical insurance, 
employment, government subsidization, and dependent variable, dialysis utilization while 
controlling the covariates. This study's data includes descriptive statistics using 
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categorical data to measure and compare crosstabulations, chi-square analysis, frequency 
distributions, and counts between groups. Conducting a multivariable analysis helped 
establish the relationship between the dependent and the independent variables (Creswell 
& Creswell, 2018). The findings of this study may provide information about current 
CKD trends. They may reduce the literature gap about government subsidization's 
efficacy and the relationship between health insurance and employment on dialysis 
utilization for CKD patients in Saint Lucia.  
Finally, the primary analysis was conducted to address the three RQs. The binary 
logistic regression analysis was performed three times. If the p-value is less than .05, then 
the relationship between the dependent and independent variables in the model is 
statistically significant. If the p-value is less than .05, then the odds ratios will be 
reviewed to determine which independent variable makes a considerable contribution to 
the model. The target populations consist of males and females 18 years and older 
diagnosed with CKD in Saint Lucia throughout 2015-2019. Additionally, the target 
population is limited to the race categories: African descent, East Indian, Mixed, or other.  
Threats to Validity 
Internal validity refers to whether the conclusions that are reached in a study are 
trustworthy, meaningful, and accurate (Heinze et al., 2018; Creswell & Creswell, 2018). 
One threat to internal validity is maturation. It may be that the passing of time and the 
progression of their disease affects their ability to access dialysis treatment and not 
financial factors. Another threat to internal validity is confounding. Confounding refers to 
changes in an outcome variable that is thought to have resulted from a third variable. It 
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may be that dialysis utilization may be affected by other factors such as patient health 
literacy level. External validity refers to the generalizability of a study (Creswell & 
Creswell, 2018).  
Ethical Procedures 
The data from the Renal Registry is made available for download through the 
Minsity of Health. The data file contains no personally identifiable information in the 
data, so there is no concern for confidentiality violations. Once the analysis was 
completed and the report was written, the data was stored in a secure, password-protected 
computer that was not connected to the internet. All IRB protocols were followed to 
ensure no violations of ethical research standards or IRB regulations. 
Summary 
The purpose of this proposed quantitative causal-comparative research study was 
to examine dialysis utilization based on CKD patient’s health insurance status, 
government subsidization, and employment status using a retrospective cohort study 
design for the five years from January 2016 to December 2019. The sample was obtained 
from secondary data in an existing Ministry of Health National Renal Registry extracted 
from all dialysis clinics in Saint Lucia. Descriptive analyses were performed to describe 
the study population and provide the means, standard deviations, frequencies, a range of 
scores, and percentages (Creswell & Creswell, 2018).  
The data analysis process consisted of three phases; the data preparation phase, 
the preliminary analysis phase, and the primary analysis phase. The relationship between 
health insurance, subsidization, employment, and dialysis utilization was examined using 
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binary logistic regression analysis to predict a correlation while controlling the 
covariates. This study's data includes descriptive statistics using categorical data to 
measure and compare with crosstabulations, chi-square analysis, frequency distributions, 
and counts between groups. The primary analysis was conducted to address the three 
RQs. The multiple linear regression analysis was performed three times. If the p-value 
was less than .05, then the model as-a-whole is significant. If the p-value was less than 
.05, then the odds ratios were reviewed to determine which groups significantly 
contributed to the model.  
 Due to limited research on the efficacy of government subsidization for dialysis 
in Saint Lucia, this study was geared toward providing information on the relationship 
between subsidization and dialysis utilization and insight into future payment models and 
disease management initiatives. Furthermore, the study findings may provide insight into 
the financial barriers that affect dialysis utilization in the management of CKD and, thus, 
contribute to health service delivery improvement initiatives to remedy these barriers and 
improve access and quality of care for CKD patients in Saint Lucia.  
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Section 3: Presentation of the Results and Findings 
Introduction 
The study's purpose was to determine if a relationship existed between health 
insurance, employment, subsidization, and dialysis utilization among CKD patients in 
Saint Lucia.  It sought to gain information about the government subsidization program's 
efficacy for dialysis treatment. This study was the first examination of CKD 
characteristics in the population of Saint Lucia. The following RQs were addressed 
through various statistical analyses: 
RQ1: Is there a relationship between health insurance and dialysis utilization for 
CKD patients, when controlling for age, race, gender, geographical location, CKD stage, 
and attending hospital in Saint. Lucia? 
H01: There is no statistically significant relationship between health insurance and 
dialysis utilization for CKD patients when controlling for age, race, gender, 
geographical location, CKD stage, and attending hospital in Saint. Lucia. 
Ha1: There is a statistically significant relationship between health insurance and 
dialysis utilization for CKD patients when controlling for age, race, gender, 
geographical location, CKD stage, and attending hospital in Saint. Lucia. 
RQ2: Is there a relationship between employment and dialysis utilization for CKD 
patients when controlling for age, race, gender, geographical location, CKD stage, and 
attending hospital in Saint. Lucia? 
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H02: There is no statistically significant relationship between employment and 
dialysis utilization for CKD patients when controlling for age, race, gender, 
geographical location, CKD stage, and attending hospital in Saint. Lucia. 
Ha2: There is a statistically significant relationship between employment and 
dialysis utilization for CKD patients when controlling for age, race, gender, 
geographical location, CKD stage, and attending hospital in St. Lucia. 
RQ3: Is there a relationship between government subsidization and dialysis 
utilization for CKD patients in Saint Lucia? 
H03: There is no statistically significant relationship between government 
subsidization and dialysis utilization for CKD patients in Saint Lucia. 
Ha3: There is a statistically significant relationship between government 
subsidization and dialysis utilization for CKD patients in Saint Lucia. 
In this section, I describe the secondary data set and the analyses used to address 
the RQs. The statistical analyses, crosstabulations, chi-square analysis, frequency 
distributions, counts between groups, and statistical hypothesis testing are presented. I 
discuss whether the results are statistically significant and whether the null hypotheses 
were rejected or failed to be rejected.  
Data Collection of Secondary Data Set 
I obtained secondary deidentified data from the Ministry of Health renal registry. 
Raw data are collected by the Ministry of Health from all dialysis clinics at the various 
hospitals through the Central Statistics Office. These data are updated periodically. The 
Central Statistics Office required time to update the data and have it coded to maintain 
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confidentiality before handing it over for processing. Despite obtaining official IRB 
approval from the Ministry of Health and Walden University, I had to seek additional 
authorization from each hospital to use their data for research purposes per the research 
ethics protocols for Saint Lucia. Therefore, before the data set was released, I contacted 
each hospital and provided key staff with a copy of IRB approvals. Once I obtained final 
approvals, the data set was then released for analysis. A password-protected Microsoft 
Excel file containing the data set was submitted electronically to me, including all the 
required variables for analyses.  
The sample included 979 CKD patients belonging to one of three hospitals on the 
island: Tapion Hospital, Owen King European Union Hospital, and St. Jude Hospital. 
Patients in the sample were placed into three race categories: African, West Indian, and 
Mixed. They were coded into one of 10 district categories: Anse La Raye, Canaries, 
Castries, Choiseul, Dennery, Gros Islet, Laborie, Micoud, Soufriere, and Vieux Fort. The 
sample represented patients diagnosed with CKD registered in the renal registry and 
accessed dialysis treatment for 2015–2019. This study sought to determine whether there 
was a relationship between employment, insurance, subsidization, and dialysis utilization 
and assess the government subsidization program's efficacy for CKD patients requiring 
dialysis. The sample population included in the data set was appropriate for this study. 
Data Analysis 
I undertook a preliminary coding exercise for each of the variables to facilitate 
data processing in IBM-SPSS Statistics Version 26.0. The data were thoroughly reviewed 
and checked at the case and variable level for consistency to ensure successful 
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importation into IBM-SPSS Statistics Version 26.0 and eventual interpretation of the 
results. Additionally, data adjustments were made using Microsoft Excel before 
transferring it into SPSS. I implemented various values coding and parameter settings for 
each variable. 
The first procedure performed in IBM-SPSS Statistics Version 26.0 was running 
the frequency tables for each variable to report on basic descriptive statistics that would 
help understand each variable and the dataset by extension. Most importantly, the 
frequency tables reported zero missing cases. This indicated that the data entry process 
was successful and that the data was ready for further analysis. The second procedure 
performed in IBM-SPSS Statistics Version 26.0 was the generation of crosstabs for 
relevant variables such as  
• dialysis utilization and insurance 
• dialysis utilization and employment 
• dialysis utilization and subsidization 
• dialysis utilization and gender 
• dialysis utilization and race 
• dialysis utilization and district 
• district and gender 
• hospital and subsidization 
The third procedure performed in SPSS before running the multiple logistic 
regression analysis checked for multicollinearity between independent variables to ensure 
that the regression analysis would be valid. I present these results and conclusions in the 
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section on correlation and multicollinearity. The fourth procedure was multiple logistic 
regression analysis between the dependent variable (dialysis utilization). It combined 
independent variables (insurance, employment, and subsidization) to determine whether a 
relationship/dependence between these variables existed. The statistics applied were 
Pearson’s chi-square test to determine statistical significance between variables. Cox & 
Snell R Square and Nagelkerke R Square were employed to assess the strength of the 
independent variables' impact on the dependent variable. The interpretation of results will 
be addressed later on in this section. 
Ultimately, I performed separate chi-square tests for each independent variable 
against the dependent variable to determine whether there was any 
relationship/dependence between them separately and respond to each RQ and test-
related hypotheses. Statistics applied to measure the strength of the association were eta 
statistic, and phi-Cramer’s V. The results and interpretations are presented later on in this 
section.  
Results 
Frequency tables for each variable are presented to report on basic descriptive 
statistics that would help understand each variable and the dataset by extension. This is 
important to this study because it is the first time this population was investigated in Saint 
Lucia. As shown in Table 1, the sample comprised 979 CKD patients. Covariates for this 
study included age, race, geographical location or district, CKD stage, CKD Cause, and 
attending hospital. Given that this study is the first to provide descriptive statistics about 
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the CKD population in Saint Lucia, I examined the frequencies for this population across 
the variables.  
 
Table 1 
Frequency Table: General Statistics of CKD Population  
 Covariate 









979 979 979 979 979 979 
0 0 0 0 0 0 
Mode 2 1 3 5 2 1 
Range 1 2 10 4 2 7 
Minimum 1 1 1 1 1 1 
Maximum 2 3 11 5 3 8 
 
As shown in Table 2, the CKD population in this study comprised 470 males and 
509 females, representing a ratio of 0.48:0.52, male to female. According to the Institute 
for Health Metrics and Evaluation (2020), Saint Lucia’s population is 182,790, with the 
male population is 90,019 and the female population is 92,771. Given the country’s 
gender demographic, it is essential to note that the CKD population mirrors that 
distribution, where more females make up the CKD population.  
Table 2 
Frequency Table: Gender of CKD Population 
Gender 























Saint Lucia’s population is predominantly of African Descent/black (85.3% of the 
total population), followed by mixed African-European or mixed African- India descent 
(11% of the total population), then West Indian (2.2% of the total population) and white 
(0.6% of the total population). For this study, the CKD population fell within 1 of 3 
ethnic groups (African Descent, West Indian, and mixed). Since there were no 
individuals of white descent in the dataset, this category was omitted during the coding 
and analysis process. As shown in Table 3, the largest CKD population consists of 93.3 
% African Descent (913 of the total CKD population). 4.4% of the CKD population were 
West Indian (43 of the total CKD population), and 2.3% of the CKD population were 
mixed (23 of the total CKD population). 
Table 3 
Frequency Table: Race of CKD Population 
Race 
  Frequency Percent Valid Percent Cumulative Percent 
 
African Descent 913 93.3 93.3 93.3 
West Indian 43 4.4 4.4 97.7 
Mix 23 2.3 2.3 100 
Total 979 100 100 
 
 
As shown in Table 4, the median age of this sample population was 65 years. The 




Frequency Table: Age Distribution of CKD Population 
 
Saint Lucia has 11 districts: Anse La Raye, Canaries, Castries, Choiseul, Dennery, 
Forest Reserve, Gros Islet, Laborie, Micoud, Soufriere, and Vieux Fort.  For this study, 
District 6, a Forest Reserve, was omitted because none of the Saint Lucian population 
reside in this geographical area. As shown in Table 4, the largest CKD population 
districts were the three major cities, Castries, Vieux Fort, and Gros Islet. Castries, which 
is the capital city, located to the north of the island, comprised 33.5% of the CKD 
population (328 of the total CKD population), Vieux Fort, the second-largest city, located 
to the south of the island, comprised 22.4% of the CKD population (219 of the total CKD 
population). Gros Islet, a city in the north of the island, comprised 13.4% of the CKD 
population (131 of the total CKD population).  
Age 
               Mean                                                                                                            63.39 
               Median                                                                                                            65 
               Std. Deviation                                                                                              14.107 
               Range                                                                                                             82 
               Minimum                                                                                                         20 




Frequency Table: Geographical Location of CKD Population 
District 
 Frequency Percent Valid Percent Cumulative 
Percent 
Anse La Raye 28 2.9 2.9 2.9 
Canaries 1 0.1 0.1 3 
Castries 328 33.5 33.5 36.5 
Choiseul 39 4 4 40.4 
Dennery 92 9.4 9.4 49.8 
Gros Islet 131 13.4 13.4 63.2 
Laborie 47 4.8 4.8 68 
Micoud 58 5.9 5.9 74 
Soufriere 36 3.7 3.7 77.6 
Vieux Fort 219 22.4 22.4 100 
Total 979 100 100 
 
 
The kidneys of individuals diagnosed with CKD do not usually fail at once. 
Kidney disease often progresses slowly over five years. Consequently, if CKD is detected 
early, medication and lifestyle changes may slow its progression (CDC, 2019). The NKF 
(2020) divided kidney disease into five stages. The GFR is the best measure of kidney 
function. The GFR is calculated using the math formula, including a person’s age, race, 
gender, and serum creatinine (NKF, 2020). The NKF (2020) further explains that 
Creatinine is a waste product that comes from muscle activity. When kidneys are working 
well, they remove creatinine from the blood as kidney function slows and creatinine 
levels rise. The five stages of CKD are presented in Figure 4. The GFR number tells how 




Stages of Chronic Kidney Disease 
 
 
Note. The National Kidney Foundation, 2020 
 
As shown in Table 6, the Saint Lucian CKD population falls within these five 
groups or stages. Stage 1 and 2 comprise 2 (0.2%) and 7 (0.7%) individuals respectively. 
The second-largest group was at Stage 3, representing 41.6% of the CKD population (407 
of the total CKD population). Stage 4 comprised 13.7% of the CKD population (134 of 
the total CKD population). As revealed in this study, the largest group was Stage 5 or 
ESRD, accounting for 43.8% of the CKD population in Saint Lucia (429 of the total 




Frequency Table: CKD Stage of CKD Population 
CKD Stage 











Stage 3 407 41.6 41.6 42.5 
Stage 4 134 13.7 13.7 56.2 
ESRD/Stage 5 429 43.8 43.8 100 
Total 979 100 100 
 
 
CKD patients were treated at any one of the three hospitals’ dialysis clinics. From 
2015 to 2019, Tapion Hospital (Private hospital) treated 0.9% of the CKD population (9 
of the total CKD population). St. Jude Hospital (Statutory hospital) treated 36.1% of the 
CKD population (353 of the total CKD population), and Owen King European Union 
Hospital (the major public hospital on the island) treated 63% of the CKD population 
(617 of the total CKD population) for the same period. It is not surprising that the Owen 
King European Union Hospital served the most significant CKD population. It is the only 
major public hospital in Saint Lucia situated in one of the most populated regions. Table 
7 clearly outlines the frequency distribution of the CKD population across hospitals. 
Table 7 
 
Frequency Table: Attending Hospital 
Upon assessing the data set, the cause of CKD for that population was a myriad of 
conditions. As a result of the long list of causes of CKD for those analyzed in this data 
Hospital 
 Frequency Percent Valid Percent Cumulative 
Percent 
Tapion Hospital 9 0.9 0.9 0.9 
OKEU Hospital 617 63 63 63.9 
St. Jude Hospital 353 36.1 36.1 100 




set, I categorized the causes into eight categories: Category 1: Hypertension and Diabetes 
Mellitus with no other preexisting cause, category 2: Hypertension with no other 
preexisting cause; category 3: Diabetes Mellitus with no other preexisting cause, category 
4: Hypertension, Diabetes Mellitus and other combinations such as polycystic kidney 
disease (PKD), congestive heart failure (CHF), angina, prostate cancer, peripheral venous 
disease (PVD), Parkinson, and metabolic syndrome; category 5: Hypertension and other 
combinations such as, polycystic kidney disease, morbid obesity, dyslipidemia, prolapse 
uterus, glaucoma, valvopathy, seizure disorder, venous insufficiency, cerebral aneurysm, 
acute kidney injury, and proteinuria, hematuria and pagets; category 6: Diabetes Mellitus 
and other combinations such as, solitary kidney, HIV, glomerulopathy, and 
nephrolithiasis; category 7: Other causes such as, PKD, CHF, calculus, sickle cell 
disease, lupus, chronic venous ulcers, immunocompromised, obesity, multiple myeloma, 
kidney stones, and depression. The final category comprised unknown cause. 
As shown in Table 8, the most common cause of CKD was a combination of 
hypertension and diabetes mellitus with no other cause, accounting for 40.6% of the CKD 
population (397 of the total CKD population). The second most common cause of CKD 
was hypertension only, accounting for 25.5% of the CKD population examined (250 of 
the total CKD population). The third most common cause of CKD was a combination of 
hypertension, diabetes mellitus, and other diseases or conditions, accounting for 12.9% of 
the CKD population (126 of the total CKD population). According to this data, the fourth 
leading cause of CKD was hypertension and a combination of other diseases or 
conditions, accounting for 10.4% of the CKD population (102 of the total CKD 
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population). CKD caused by diabetes mellitus alone accounted for 2.9% of the CKD 
population (28 of the total CKD population), and diabetes mellitus with a combination of 
other diseases or conditions accounted for 1.6% of the CKD population (16 of the total 
CKD population). CKD caused by other conditions or diseases other than hypertension 
and or diabetes mellitus accounted for 5.5% of the CKD population (54 of the total CKD 
population). Finally, 0.6% of CKD was caused by unknown conditions or diseases in this 
study (6 of the total CKD population). 
Table 8 
Frequency Table: Cause of CKD 
Cause of CKD  
  Frequency Percent Valid Percent Cumulative Percent 
HTN, DM 397 40.6 40.6 40.6 
HTN 250 25.5 25.5 66.1 
DM 28 2.9 2.9 68.9 
HTN, DM, Combinations 126 12.9 12.9 81.8 
HTN, Combinations 102 10.4 10.4 92.2 
DM, Combinations 16 1.6 1.6 93.9 
Other Causes 54 5.5 5.5 99.4 
Unknown 6 0.6 0.6 100 
Total 979 100 100 
 
 
Note. “DM” refers to Diabetes Mellitus and “HTN” refers to Hypertension. 
 
One of the independent variables that this study sought to examine was 
employment. As shown in Table 9, from the total of 979 CKD patients in this study, 
20.8% had some form of employment (204 of the total CKD population). The majority of 
the CKD population were unemployed, accounting for 79.2% of the CKD population 





Frequency Table: Employment Status of CKD Population 
Employment Status 
 Frequency Percent Valid Percent Cumulative Percent 











Saint Lucia does not have a national health insurance program for its citizens 
covering care for CKD patients. Therefore such individuals seek coverage from private 
insurance companies. Consequently, most individuals who have some form of medical 
insurance would obtain this as a benefit of their employment. As shown in Table 10, most 
of the CKD population were uninsured in this study. 94.6% of the CKD population had 
no form of medical insurance, accounting for 926 of the total CKD population. Only 
5.4% of the CKD population had some form of insurance (53 of the total CKD 
population). These findings will be further explained later on in this section. 
Table 10 
 
Frequency Table: Insurance Status of CKD Population 
 
Insurance 
 Frequency Percent Valid Percent Cumulative Percent 
Yes 53 5.4 5.4 5.4 
No 926 94.6 94.6 100 
Total 979 100 100 
 
 
A very significant variable in this study was subsidization for dialysis. For a basic 
overview of this variable, frequency distribution was performed. As was shown in Tables 
9 and 10, very few CKD patients are employed and or have medical insurance. As a 
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result of the prevalence and incidence of CKD in Saint Lucia, the government has 
implemented a dialysis subsidization program to assist patients in treating this disease 
(Government of Saint Lucia, 2018).  
Table 11 shows the number of CKD patients receiving full subsidization, partial 
subsidization, and no subsidization. 66.1% received no subsidization (representing 647 of 
the total CKD population). These individuals consisted of persons at stages 1 to 4 who 
did not receive dialysis (only Stage 5 or ESRD receive dialysis treatment), persons who 
rejected treatment, and persons at stage 5 or ESRD awaiting treatment. Further analysis 









Frequency Table: CKD Population Accessing Dialysis 
 
Dialysis Utilization 




None 699 71.4 71.4 71.4 
Once a Week 1 0.1 0.1 71.5 
Twice a Week 51 5.2 5.2 76.7 
Three times a Week 228 23.3 23.3 100 





 Frequency Percent Valid Percent Cumulative Percent 
None 647 66.1 66.1 66.1 
Full Subsidization 64 6.5 6.5 72.6 
Partial Subsidization 268 27.4 27.4 100 
Total 979 100 100 
 






Multiple Logistic Regression for Combined Variables: Case Summary 
 
Case Processing Summary 
Unweighted Cases N Percent 
Selected Cases Included in Analysis 979 100.0 
Missing Cases 0 0.0 
Total 979 100.0 
Unselected Cases 0 0.0 
Total 979 100.0 
a. If weight is in effect, see classification table for the total number of cases. 
 
Note. This table shows the number of cases considered in this test. It includes 979 cases 
with 0 cases excluded or missing. 
Table 14 shows encoding for the dependent variable, dialysis utilization. The 
binary coding, yes =1; “meaning uses Dialysis,” No=0; “meaning not using Dialysis.” 
This also meant that the model would be predicting the odds of ‘Yes”, or the odds of 
dialysis utilization as the answer "Yes" had been given the larger internal value code in 
the model. Yes =1, No=0. 
Table 14 
Dependent Variable Coding  
Dependent Variable Encoding 




Note. Dialysis Utilization Coding for logistic regression analysis 
Table 15 shows a standard correlation matrix as performed in SPSS for the 
independent variables (Employment, Insurance, and Subsidization) and dependent 
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variable (dialysis utilization) in the study. This step is important before running the 
multiple logistic regression to determine and treat (if necessary) for multicollinearity in 
independent variables. Multicollinearity will cause unstable estimates and inaccurate 









1 .389** -.136** -.108** 
Sig. (2-
tailed) 
  0 0 0.001 
N 979 979 979 979 
INSURANCE Pearson 
Correlation 
.389** 1 -0.028 -0.048 
Sig. (2-
tailed) 
0   0.38 0.135 
N 979 979 979 979 
SUBSIDIZATION Pearson 
Correlation 
-.136** -0.028 1 .777** 
Sig. (2-
tailed) 
0 0.38   0 





-.108** -0.048 .777** 1 
Sig. (2-
tailed) 
0.001 0.135 0   
N 979 979 979 979 
**. Correlation is significant at the 0.01 level (2-tailed). 
 
Multicollinearity happens in a regression model when the independent variables 
are correlated. The degree of change in one variable is closely affected by the change in 
another independent variable. If the degree of correlation is high and not corrected, this 
may result in undesirable results after running the regression analysis (Frost, 2021). 
Although it was observed that there was some correlation between employment and 
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insurance (p= .389) and employment and subsidization (p= -.136) however, observing the 
correlation table was not enough to explain multicollinearity between these variables and 
therefore the study applied further analysis of the collinearity statistics tolerance and its 
reciprocal called the variance inflation factor (VIF) as shown in Table 16. 
 
Table 16 






t Sig. Collinearity Statistics 
B Std. 
Error 
Beta Tolerance VIF 
1 (Constant) 0.14 0.08 
 
1.746 0.08     
EMPLOYMENT 0.01 0.025 0.009 0.417 0.68 0.833 1.2 
INSURANCE -0.06 0.044 -0.029 -1.349 0.18 0.848 1.179 
SUBSIDIZATION 0.397 0.01 0.777 38.21 0 0.981 1.02 
a. Dependent Variable: Dialysis Utilization 
 
In the collinearity statistics, tolerance measures the percentage of the variance in a 
given predictor variable (employment, insurance, subsidization) that the other predictors 
cannot explain. Although there is no formal threshold value for this, the literature 
suggests that a tolerance below 0.2 suggests serious collinearity (Senaviratna et al., 
2019). The Collinearity statistic for all of the independent variables in Table 16 is closer 
to 1, meaning that there is very little correlation between them. 
Further, the VIF shows how much the variance of the coefficient estimate is 
inflated by multicollinearity. Again, like the tolerance statistic, there is no formal cutoff 
value for the VIF for determining multicollinearity. However, it is generally accepted that 
values of VIF that exceed 10 indicate multicollinearity. In logistic regression, values 
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above 2.5 may cause concern (Midi et al., 2010). In this study, the VIF numbers were 
below the considered 2.5 threshold for all variables in the model. 
The findings of the collinearity statistics of tolerance and the variance inflation 
factor for all of the independent variables led to the conclusion that correlation among 
these variables was not substantial. Therefore these variables could not be voided during 
the process of performing the multiple logistic regression and hypothesis testing to 
answer the associated RQs. 
The Categorical Variables Coding Table 17 shows the frequencies of the various 
independent variables that were forced into the model. In the independent variable 
category, subsidization, 647 patients received no subsidization. Of the 332 that receive 
subsidization, 268 patients received partial subsidization, and 64 patients received full 
subsidization. In the insurance category, 926 patients were uninsured, and 53 patients 
were insured. In the employment category, 775 patients were unemployed, and 204 were 
employed. 
Table 17 
Logistic Regression: Independent Variable Coding 
Categorical Variables Codings 
  Frequency Parameter coding 
(1) 
SUBSIDIZATION No 647 1 
Yes 332 0 
INSURANCE yes 53 1 
No 926 0 
EMPLOYMENT Yes 204 1 




It revealed each independent variable's categories, manually recoded into the 
regression as dummy variables under parameter coding (1). In logistic regression, just as 
in linear regression, groups are compared to each other. One group has to be omitted 
from the comparison to serve as the baseline category (Creswell & Creswell, 2018). In 
this case, for each independent variable, one dummy variable was selected as the 
constant. In subsidization, “No” was selected as constant, to which predictions for “Yes” 
were compared. Likewise, in insurance, "No" was constant to which predictions for Yes 
were compared in this category, and employment "No" was selected automatically, 
against which employment "Yes" were compared.  
Table 18 
Classification Table  
Classification Tablea,b 
Observed Predicted 
Dialysis Utilization Percentage Correct 
No Yes  
Dialysis Utilization No 698 0 100.0 




a. Constant is included in the model. 
b. The cut value is .500 
 
Table 18 shows predictions for the dependent variable “use of dialysis” without 
introducing any independent variables into the regression. In other words, the odds that a 
patient may not use dialysis without taking into account employment, insurance, or any 
level of subsidization was predicted at roughly 71.3%. For example, suppose a case 
would be selected randomly from the CKD cases in Saint Lucia. In that case, the 
likelihood of selecting someone who does not use dialysis is predicted at 71.3% higher 
compared to selecting someone who uses dialysis. This reflects the existing ratio of 
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dialysis non-users compared to persons using dialysis in the sample. Numerically 
represented as:  
 
Table 19 
Variables in the Equation 
Variables in the Equation 
  B S.E. Wald df Sig. Exp(B) 
 
Constant -0.910 0.071 165.856 1 0.000 0.403 
 
In Table 19, the Odds of dialysis utilization by a CKD patient is shown. The odds 
ratio represented by the Exponential B; Exp(B) means that without the addition of any of 
the independent variables, the odds of using dialysis was predicted at 0.403, representing 
the odds that a CKD patient would not use dialysis. 
Table 20 
 Multiple Regression model 
Multiple Regression Table  
  Score df Sig. 
Variables EMPLOYMENT(1) 11.443 1 0.001 
INSURANCE(1) 2.234 1 0.135 
SUBSIDIZATION (1) 679.773 1 0.000 
Overall Statistics 681.31 3 0.000 
 
 Table 20 shows the significance of each independent variable related to the 
dependent variable, dialysis utilization. For satisfying the logistic regression 
requirements, two variables in this analysis were recoded from their original multiple tier 
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responses to binary coding1. If "P" (Sig.) is less than 0.05, then the model determines that 
these independent variables' relationship to the dependent variable is significant. In this 
case significance of the independent variable, employment is lower than the threshold of 
0.05; therefore, it is significant, just as is the case with subsidization. Insurance was not 
significant in the model with a p-value of 0.135, which is above the threshold of 0.05. 
This may be influenced by the comparatively low number of patients with insurance in 
the model. However, this multiple logistic regression model had an overall significance 
level of 0.00, meaning that the independent variables (Employment and Subsidization) 
did influence dialysis utilization. This was supported by the results of the Omnibus Tests 
of Model Coefficients in Table 21. Each of these independent variables will also be 
individually tested (Chi-square test) against the dependent variable (dialysis utilization) 
to determine the strength of significance and respond to each RQ separately. 
Table 21 
Omnibus Tests of Model Coefficients  
Omnibus Tests of Model Coefficients 
  Chi-square Df Sig. 
Step 1 Step 771.795 4 0.000 
Block 771.795 4 0.000 
Model 771.795 4 0.000 
 
Note. Block 1: Method =Enter 
 
Table 21 shows the multiple logistic regression results, including both dependent 
variable (dialysis utilization) and Independent Variables (Employment, Insurance, and 
 
• 1 Dialysis Utilization was recoded from responses “0=None, 1= Once Weekly, 2=Twice Weekly, 3 = Three 
times weekly”, to Binary coding “0=No” for None, and “1=Yes”, for all responses other than None.  
• Subsidization was recoded from responses “0=None, 1= Full subsidization, 2=Partial Subsidization” to 
Binary coding “0=No”for None and “1=Yes”, for all responses other than None. 
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Subsidization). The "Omnibus Tests of Model Coefficients" show the result of a chi-
square test to determine whether or not the independent variables' addition has a 
statistically significant relationship with the dependent variable (Creswell & Creswell, 
2018), dialysis utilization. This chi-square Test returned the value of 0.000, indicating a 
statistically significant relationship between dialysis utilization and employment and 
dialysis utilization and subsidization. 
Table 22 provides pseudo-R-squared measures of Cox & Snell and Nagelkerke. 
These R-Square measures inform on the variability in the dependent variable (Creswell & 
Creswell, 2018); dialysis utilization was explained by the independent variables, 
employment, and subsidization. Cox & Snell R-squared determines that this model 
explains 54.5% of the variation in dialysis utilization. In contrast, Nagelkerke R-Squared 
determines that this model explains 78.1% variation in dialysis utilization. In both 
instances, however, this reveals implicitly that other factors outside of this model 
influence dialysis utilization.  
Table 22 
Cox & Snell and Nagelkerke R Square Measures 
Model Summary 
Step -2 Log likelihood Cox & Snell R Square Nagelkerke R 
Square 
1 401.965a 0.545 0.781 
a. Estimation terminated at iteration number 7 because parameter estimates changed by 
less than .001. 
 
The Pearson chi-square significance level of 0.135, shown in Table 23, was above 
the recommended significance level of 0.05, indicating that the association between 
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insurance and dialysis utilization was not significant. Insurance in the model is not a 











Pearson Chi-Square 2.234a 1 0.135 
  
Continuity Correctionb 1.792 1 0.181 
  
Likelihood Ratio 2.125 1 0.145 
  







2.232 1 0.135 
  
N of Valid Cases 979   
   
a. 0 cells (0.0%) have expected count less than 5. The minimum expected count is 15.21. 
b. Computed only for a 2x2 table 
 
Further, the eta statistic application to measure the level of variability in the 
dependent variable accounted for by the independent variable is reported in Table 24. 
Table 24 shows the crosstabs for independent variable Insurance against 
dependent variable, dialysis utilization. The observed and expected count values for 
dialysis utilization (Yes, No) were recorded against Insurance (Yes, No). The expected 
count shows what should be expected or observed if the independent variable had no 
relationship to the dependent variable. The chi-square test helps determine if the observed 
counts are different enough for the association between these two variables to be 




















Pearson Chi-Square 2.234a 1 0.135 
  
Continuity Correctionb 1.792 1 0.181 
  
Likelihood Ratio 2.125 1 0.145 
  







2.232 1 0.135 
  
N of Valid Cases 979   
   
a. 0 cells (0.0%) have expected count less than 5. The minimum expected count is 15.21. 
b. Computed only for a 2x2 table 
 
The Pearson chi-square significance level was at 0.135, as shown in Table 25, 
above the recommended significance level of 0.05, which indicates that the association 
between insurance and dialysis utilization is not significant. Insurance in the model is not 
a significant predictor of dialysis utilization. RQ1 and its associated hypotheses were as 
follows: 
Dialysis Utilization * INSURANCE Crosstabulation 
  INSURANCE Total 
yes No 
Dialysis Utilization No Count 33 665 698 
Expected Count 37.8 660.2 698.0 
Yes Count 20 261 281 
Expected Count 15.2 265.8 281.0 
Total Count 53 926 979 





RQ1: What is the relationship, if any, between health insurance and dialysis 
utilization for CKD patients when controlling for age, race, gender, geographical 
location, CKD stage, CKD cause, and attending hospital in Saint. Lucia?   
H01: There is no statistically significant relationship between health insurance and 
dialysis utilization for CKD patients when controlling for age, race, gender, 
geographical location, CKD stage, CKD cause, and attending hospital in Saint 
Lucia.  
Ha1: There is a statistically significant relationship between health insurance and 
dialysis utilization for CKD patients when controlling for age, race, gender, 
geographical location, CKD stage, CKD cause, and attending hospital in Saint. 
Lucia. 
Based on the “P” value of 0.135 from the multiple regression model (Table 20) 
and the Pearson chi-square significance level of 0.135 (Table 23), insurance did not have 
a statistically significant relationship with dialysis utilization; therefore, the null 
hypothesis for RQ could not be rejected. Therefore, dialysis utilization is not necessarily 
dependent on whether or not a patient has Insurance in this study. While the relationship 
did not meet the threshold for statistical significance, it did “approach significance.” This 
may be reflective of the comparatively low number of patients with insurance. Further, 
the Eta Statistic application to measure the level of variability in the dependent variable 




Eta Statistic for Insurance 
Directional Measures 
  Value 
Nominal by Interval Eta Dialysis Utilization 
Dependent 
0.048 
INSURANCE Dependent 0.048 
 
Eta-squared is the most typically reported measure of effect size in measuring 
variance analysis (Creswell & Creswell, 2018). It represents the percentage of variance in 
the dependent variable accounted for by the independent variable. Eta-Squared as regards 
to the effect of insurance in dialysis utilization was; η2 = 0.0482 = 0.002304 * 100 = 
0.23%. Only 0.23% (less than half a percent) of the dialysis utilization variance was 
accounted for by insurance. 
The Pearson Chi-Square significance level is at 0. 001 as shown in Table 28. This 
was below the recommended significance level of 0.05, indicating that the association 
between employment and dialysis utilization is significant. Employment in the model is a 
significant predictor of dialysis utilization. 
Table 27 
Crosstabulations: Dialysis Utilization and Employment 
Dialysis Utilization * EMPLOYMENT Crosstabulation 
  EMPLOYMENT Total 
Yes No 
Dialysis Utilization No Count 126 572 698 
Expected Count 145.4 552.6 698 
Yes Count 78 203 281 
Expected Count 58.6 222.4 281 
Total Count 204 775 979 





Chi-Square Tests: Dialysis Utilization and Employment 
Chi-Square Tests 













10.862 1 0.001 
  
Likelihood Ratio 10.995 1 0.001 
  
Fisher's Exact Test 




11.431 1 0.001 
  
N of Valid Cases 979 
    
a. 0 cells (0.0%) have expected count less than 5. The minimum expected count is 58.55. 
b. Computed only for a 2x2 table 
 
RQ2 and its associated hypotheses were as follows: 
RQ2: What is the relationship, if any, between employment and dialysis 
utilization for CKD patients when controlling for age, race, gender, geographical 
location, CKD stage, CKD cause, and attending hospital in Saint. Lucia? 
H02: There is no statistically significant relationship between employment and 
dialysis utilization for CKD patients when controlling for age, race, gender, 
geographical location, CKD stage, CKD cause, and attending hospital in Saint. 
Lucia.  
Ha2: There is a statistically significant relationship between employment and 
dialysis utilization for CKD patients when controlling for age, race, gender, 




The model does present a degree of significance enough to reject the Null 
Hypothesis, H02. Therefore, dialysis utilization is somewhat influenced by whether or not 
a patient is employed. The relationship between employment and dialysis utilization is 
statistically significant. Further application of the Eta Statistic to measure the level of 
variability in dialysis utilization accounted for by the employment is reported in Table 29. 
Eta-squared is the most typically reported measure of effect size in measuring 
analysis of variance. It represents the percentage of variance in the dependent variable 
accounted for by the independent variable. Eta-Squared as regards to the effect of 
employment on dialysis utilization is; η2 = 0.1082 = 0.011664 * 100 = 1.16%. at least 
1.16% of the variance in dialysis utilization is accounted for by employment. 
 
Table 29 
Directional Measures: Dialysis Utilization and Employment 
Directional Measures 
  Value 
Nominal by Interval Eta Dialysis Utilization Dependent 0.108 





Crosstabulations: Dialysis Utilization and Subsidization 
Dialysis Utilization * SUBSIDIZATION Crosstabulation 





Dialysis Utilization No Count 636 1 61 698 
Expected 
Count 
461.3 45.6 191.1 698 
Yes Count 11 63 207 281 
Expected 
Count 
185.7 18.4 76.9 281 
Total Count 647 64 268 979 
Expected 
Count 
647 64 268 979 
 
Table 31 
Chi-Square Tests: Dialysis Utilization and Subsidization 
Chi-Square Tests 
  Value Df Asymptotic Significance (2-
sided) 
Pearson Chi-Square 691.118a 2 0.000 
Likelihood Ratio 764.511 2 0.000 
Linear-by-Linear 
Association 
590.234 1 0.000 
N of Valid Cases 979 
  
a. 0 cells (0.0%) have expected count less than 5. The minimum expected count is 18.37. 
 
The Pearson chi square significance level was at 0.000, below the recommended 
significance level of 0.05. This indicates that the association between subsidization and 
dialysis utilization is significant. Subsidization in the model is a significant predictor of 
dialysis utilization. RQ3 and its associated hypotheses were as follows: 
RQ3: What is the relationship, if any, between government subsidization and 
dialysis utilization for CKD patients in Saint Lucia?  
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H03: There is no statistically significant relationship between government 
subsidization and dialysis utilization for CKD patients in Saint Lucia.  
Ha3: There is a statistically significant relationship between government 
subsidization and dialysis utilization for CKD patients in Saint Lucia. 
The model does present a degree of significance enough to reject the null 
hypothesis, H03. Therefore, dialysis utilization is influenced by whether or not a patient 
received subsidies for dialysis. The relationship between subsidization and dialysis 
utilization was statistically significant. 
Further application of the Eta Statistic to measure the level of variability in 
dialysis utilization accounted for by the Subsidization is reported in Table 32. 
Table 32 
Directional Measures: Dialysis Utilization and Subsidization 
Directional Measures 
  Value 
Nominal by Interval Eta Dialysis Utilization Dependent 0.84 
SUBSIDIZATION Dependent 0.777 
 
Eta-squared is the most typically reported measure of effect size in measuring 
analysis of variance. It represents the percentage of variance in the dependent variable 
accounted for by the independent variable. Eta-Squared as regards to the effect of 
subsidization on dialysis utilization is; η2 = 0.7772 = 0.603729 * 100 = 60.37%. Roughly 




Through the various statistical analyses of logistic regression, chi-square, and 
crosstabulation, the three RQs for this study were answered. For RQ1, there was no 
statistically significant relationship between health insurance and dialysis utilization for 
CKD patients when controlling for age, race, gender, geographical location, CKD stage, 
CKD cause, and attending hospital in Saint. Lucia. Insurance was not statistically 
significant in the multiple regression model with a p-value of 0.135, which is higher than 
the threshold of 0.05. Additionally, the Pearson chi-square significance level of 0.135 
was above the recommended significance level of 0.05 in the model. This revealed that 
the association between insurance and dialysis utilization was not significant and that 
insurance in the model was not a significant predictor of dialysis utilization.  
Further, the Eta Statistic application measures variability in the dependent 
variable accounted for by the independent variable. In this study, only 0.23% (less than 
half a percent) of the dialysis utilization variance was accounted for by insurance. 
Therefore, the null hypothesis (H01) was not rejected. The data concluded that dialysis 
utilization was not dependent on whether or not a patient had insurance.  
The null hypotheses (H02, H03) for RQs 2 and 3 were rejected, and the alternative 
hypotheses were accepted. This study revealed a statistically significant relationship 
between employment and dialysis utilization and between subsidization and dialysis 
utilization. The multiple regression model (Table 20) returned the value of 0.000, 
respectively, for dialysis utilization and employment and dialysis utilization and 
subsidization, indicating a statistically significant relationship.  
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For RQ2, the Pearson chi-square significance level was 0.001, below the 
recommended significance level of 0.05, indicating that the association between 
employment and dialysis utilization is significant. Employment in the model is a 
significant predictor of dialysis utilization. Eta-squared regarding the effect of 
employment on dialysis utilization was 1.16%., meaning at least 1.16% of the variance in 
dialysis utilization was accounted for by employment.  
The Pearson chi-square significance level of 0.000 was below the recommended 
significance level of 0.05, indicating that the association between subsidization and 
dialysis utilization was statistically significant. Subsidization in the model was a 
statistically significant predictor of dialysis utilization. Eta squared as it pertained to the 
effect of subsidization on dialysis utilization was equal to 60.37%. Roughly 60% of the 
variance in dialysis utilization was accounted for by subsidization. These significant 
findings reveal the efficacy of the government’s subsidization program for dialysis 
treatment for CKD patients. Additionally, the findings also point out that employment 
status influenced dialysis utilization among CKD patients in Saint Lucia. These results 
provide relevant and valuable information to CKD patients' management and care in 




Section 4: Application to Professional Practice and Implications for Social Change 
Introduction 
In this study, I applied a quantitative approach with a correlational analysis to 
determine whether a relationship existed between the independent variables, health 
insurance, employment, subsidization, and the dependent variable, dialysis utilization. 
The purpose of the study was to assess the efficacy of the government’s subsidization 
program for dialysis in Saint Lucia and the utilization of hemodialysis given a patient’s 
employment status, health insurance status, or receipt of government subsidization. 
Additionally, an assessment of the CKD population's baseline characteristics in was 
carried out for the first time. I begin this section by interpreting the findings, followed by 
this study's limitations, then the recommendations, and finally, the study’s implications 
for professional practice and social change. 
Interpretation of the Findings 
This study's specific problem was the financial barriers that affect dialysis 
utilization in managing CKD patients in Saint Lucia. According to my research, this 
project was unique because it was the first to be specific to this population. This study 
was also motivated by my desire to understand better the CKD population's specific 
baseline characteristics in Saint Lucia and the impact of payment models on dialysis 
utilization. Given that government dialysis subsidization has been in effect since 1999, it 
was essential to assess this program's efficacy, which is essential to the effective 
management of CKD (Government Information Service, 2015).  
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The frequency tables provide first-time insight into some of the characteristics of 
the CKD population in Saint Lucia. I found that there was a higher percentage of females 
than males diagnosed with CKD in this study. Previous population-based studies indicate 
a higher prevalence of CKD in women (Brar & Markell, 2019); however, men were 
found to progress more rapidly to ESRD (Brar & Markell, 2019; Chang et al., 2016; De 
Rosa, et al., 2017). The literature further suggests that fewer males were screened for 
CKD or monitored conditions such as hypertension and diabetes, leading to CKD's onset 
(Chen et al., 2019). Consequently, this study suggests that lifestyle-related factors may 
also play a role in CKD's development and progression. Another finding of this study was 
that CKD's major causes in Saint Lucia were hypertension and diabetes. Support from the 
literature suggests that CKD is most commonly attributed to hypertension and diabetes 
worldwide (Chen et al., 2019; Kramer et al., 2018). I also found that the average age of 
CKD patients was 63 years. Noble and Taal (2019) postulated that CKD affects 13% of 
the adult population globally and that the prevalence rises significantly with age. Chen et 
al. (2019) also substantiated this finding by stating that kidney function deteriorates with 
aging. This finding is of significance, primarily because Saint Lucia’s average age for 
CKD falls below the average global age of 65 years, according to the CDC (2020). 
It was not surprising that the most densely populated districts in Saint Lucia, 
namely Castries, Vieux Fort, and Gros Islet, had the highest CKD patients. Districts 
situated in the outskirts of the cities and rural areas, such as Canaries and Anse La Raye, 
were reported to have fewer CKD patients. Over 90% of CKD patients in this study were 
of African descent, which mirrors the general population’s ethnic or racial distributions 
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(Pan American Health Organization, 2019). Another important finding of this study was 
the distribution of patients across CKD Stages 1 to 5. The majority of CKD patients were 
at Stages 3 and 5 (ESRD), followed by Stage 4, with fewer in the other stages. According 
to Chen et al. (2019), less than 5% of patients with early CKD report their disease 
awareness. The majority become aware when they are at advanced stages and 
symptomatic (Caribbean Renal Registry, 2018; George et al., 2017). Chen et al. could 
also explain why the numbers in this study were higher at these stages. From the 
frequencies reported on the causes of CKD, CKD's most common cause in Saint Lucia 
was a combination of hypertension and diabetes, accounting for 40.6% of the population 
examined, followed by patients with hypertension only. These results are significant 
because they provide essential information about the influence of lifestyle-related factors 
on CKD. Goro et al. (2019) suggest that CKD's burden disproportionately impacts 
LMICs, where diabetes and hypertension are the most significant risk factors for the 
CKD growth rate. 
Though this study did not include a complete exploration of the gaps and 
inequities in renal treatment therapy, hemodialysis provided relevant information and 
answered the RQs. The focus of RQ1 was on determining whether there was a 
statistically significant relationship between health insurance and dialysis utilization. 
There was no statistically significant relationship between health insurance and dialysis 
utilization for CKD patients when controlling for age, race, gender, geographical 
location, employment status, CKD stage, and attending hospital in Saint. Lucia. Insurance 
did not appear to be significant for both the multiple regression and Pearson chi-square 
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models with a low p-value of 0.135, reflective of the comparatively low number of 
patients with insurance in the study. 
Consequently, the null hypothesis for RQ1 (H01) could not be rejected. Therefore, 
dialysis utilization is not necessarily dependent on whether or not a patient has insurance. 
To further determine the percentage of variance in dialysis utilization accounted for by 
insurance, the eta-squared percentage was calculated. Less than half a percent of the 
variance in dialysis utilization was accounted for by insurance. Consequently, R-Squared 
measures (Cox & Snell and Nagelkerke) revealed that the influence of employment and 
subsidization explained more than 50% of dialysis utilization.  
The focus of RQ2 was on determining whether or not there was a statistically 
significant relationship between employment and dialysis utilization. This study found 
that the majority (more than 50%) of CKD patients on dialysis were unemployed, further 
substantiating current literature, which purports that CKD patients with ESRD face many 
barriers to remaining in the workforce after starting dialysis (Erickson et al., 2018; Hallab 
& Wish, 2018; Krishnan, 2019). In this study, further analysis using multiple regressions 
and the Pearson chi-square test revealed a p-value of 0.000, which indicated a statistically 
significant relationship between dialysis utilization and employment. Therefore these 
findings presented a degree of significance enough to reject the null hypothesis (H02). 
Eta-squared for the effect of employment on dialysis utilization accounted for at least 
1.16% of the variance in dialysis utilization. This finding is consistent with previous 
studies stating that employed persons have increased dialysis utilization than those who 
are not employed (Hallab & Wish, 2018; Norton & Eggers, 2020).  
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The focus of RQ3 was on examining the relationship between dialysis utilization 
and subsidization. I answered this question through logistic regression, chi-square 
analysis, and the eta squared statistic. The Pearson chi-square p-value of 0.000 and the 
multiple regression p-value of 0.000 revealed that the association between subsidization 
and dialysis utilization was statistically significant. That subsidization was a significant 
predictor of dialysis utilization. Consequently, dialysis utilization was influenced by 
whether or not a patient received government subsidization for dialysis. The eta statistic 
application to measure the level of variability revealed that 60% of the variance in 
dialysis utilization was accounted for by subsidization. The null hypothesis (H03) was 
rejected based on the degree of significance from the statistical measures employed. This 
finding was very significant since most CKD patients from the population were 
unemployed and uninsured, providing further evidence that the government's dialysis 
subsidization program was effective. These findings supported the current literature that 
dialysis utilization is significantly impacted by subsidization, particularly among the 
unemployed and uninsured CKD population in LMICs (Anderson, 2018; Business View 
Caribbean, 2019; Chen et al., 2019; Erickson et al., 2018). 
Limitations of the Study 
There were several limitations to this research design. Firstly, the data set was 
limited to only CKD patients who accessed dialysis from 2015 to 2019. Therefore, the 
generalizability of the findings of this study was limited. Secondly, other factors outside 
those examined influenced dialysis utilization. Further analysis of the data is encouraged 
to determine what other factors contribute to dialysis utilization. 
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Additionally, hemodialysis gaps and inequities, which may help better understand 
dialysis utilization trends, were not explored. Type of insurance coverage and its 
influence on dialysis utilization was not examined. Therefore further examination of a 
CKD patient’s type of insurance and its relation to dialysis utilization may provide 
greater insight into the impact of insurance on dialysis utilization. Additionally, though 
the relationship between insurance and dialysis utilization did not meet the statistical 
significance threshold, it did approach significance, leading to the possibility of a 
relationship. Further exploration into this relationship is encouraged by using a larger 
sample size or extending to other populations.  
Recommendations 
The study findings revealed a significant relationship between employment, 
subsidization, and dialysis utilization. Against the backdrop of a worsening economy, 
high unemployment rates, and escalation of health care costs, it was essential to examine 
the relationship between the study’s variables. There are several avenues that this 
research could be extended to build upon the current findings. One avenue for future 
research would be an analysis of CKD progression, more specifically from progression 
from stage 3 to stage 5 (ESRD). This may provide important information about the time a 
patient takes to progress from one stage to another, providing pertinent information to 
improve quality care outcomes.  Further examination of the factors other than insurance, 
employment, and subsidization that influence dialysis utilization is recommended. 
Factors such as socioeconomic status or educational background may be considered. 
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A more in-depth examination of demographics, ethnicity, and compliance to 
dialysis treatment is also recommended. This study could also be extended to 
investigating CKD incidence in Saint Lucia to help predict future cases, mainly because 
utilization heavily depends on government subsidization. This study may provide 
relevant information to health officials and other stakeholders in decision-making for the 
current subsidization program. The majority of CKD patients in this study were at stages 
5 (ESRD) or  3. Further investigation may help determine the factors contributing to 
CKD progression, particularly from stage 3 to ESRD. 
Implications for Professional Practice and Social Change 
Despite the inescapable financial obligations faced by CKD patients, their 
families, and the government in assisting in accessing dialysis treatment, the reality is 
that poor management of this condition invariably leads to even more financial burdens. 
According to De Rosa et al. (2017), patients with CKD are at high risk for developing 
other critical conditions that most often warrant admission to intensive care units. Saint 
Lucia’s already burdened health care system is not exempt from the increasing 
hospitalizations and critical care sought by CKD patients. This is further substantiated by 
this study’s findings of CKD's causes, thus leading to more economic burdens 
(Government of Saint Lucia, 2018). In the wake of health reform initiatives, an integrated 
multidisciplinary effort is necessary to adequately manage such patients' multi-organ 
damage (De Rosa et al., 2017). Current research about CKD proves vital information to 
decision-makers to develop more appropriate strategies to address this chronic disease. 
Health leaders, governments and other stakeholders should recognize the true situation of 
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CKD management in Saint Lucia. The government can only subsidize dialysis treatment 
for only a finite number of CKD patients.  As a result, this should motivate exploration of  
other preventative programs that may assist in modifying the general population's 
lifestyle choices to prevent the onset and further progression of CKD. Other studies have 
established an association between a healthy lifestyle with decreased CKD risk and 
mortality in the general population (Lee et al., 2019; Morton & Sellars, 2019). A recent 
study by Evangelidis et al. (2019) proposed that lifestyle behavior change interventions 
for CKD patients can prevent disease progression. Consequently, such initiatives can be 
implemented in resource-poor countries, or already overburdened health systems seeking 
for alternatives to curtail the increasing costs of health care for CKD patients.  
This quantitative study's findings provide insight into the financial barriers that 
affect dialysis utilization in managing CKD patients in Saint Lucia. Pertinent information 
needed by health leaders and other stakeholders are presented for the first time for this 
specific population and non-communicable disease in Saint Lucia. It will add to the 
limited research on CKD management related to health delivery (Tamura et al., 2018) in 
LMICs. Additionally, this study will inform government health officials, policy makers, 
and healthcare leaders of the efficacy of the dialysis subsidization program for CKD 
patients in Saint Lucia. This study provides a greater understanding of how government 
subsidization has impacted access to dialysis treatment. This study's information may 
contribute to health service delivery and implement policies to remedy financial barriers 
and improve access and quality of care for CKD patients in Saint Lucia (Wilk, Hirth, & 
Messana, 2019). This study's results may also provide information to both government 
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and health officials about CKD trends, financial barriers to access care for CKD patients, 
and recommendations for policy or social change improvement initiatives. 
Furthermore, the study is essentially a policy analysis of government subsidies' 
efficacy. Therefore, it is of potential societal relevance, primarily because the findings 
reveal that government subsidization positively impacts dialysis utilization. 
Consequently, policy makers, healthcare officials, and other stakeholders may obtain 
information from this study that can impact future initiatives for payment models and 
disease management of CKD in Saint Lucia.  
Conclusion 
This study, grounded in the Andersen and Newman (1995) Health Services 
Utilization Framework, sought to determine whether a relationship existed between 
insurance, employment, subsidization, and dialysis utilization. It also sought to 
determine, for the first time, the efficacy of the government subsidization program for 
dialysis in Saint Lucia and assess the CKD population's baseline characteristics in Saint 
Lucia. A literature review indicated that financial barriers such as unemployment, lack of 
insurance, and or subsidization are significant factors influencing dialysis utilization, 
particularly among LMICs. This study sought to fill the gap between the efficacy of 
government subsidization and dialysis utilization in LMICs (Caribbean Renal Registry, 
2018; Erickson et al., 2018; Li et al., 2019). While there have been numerous studies on 
financial barriers to dialysis utilization, few studies have examined government 
subsidization efficacy.  
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The research design was a quantitative causal-comparative cohort to investigate 
group populations. Same subjects (individuals diagnosed with CKD) across the period 
2015-2019 who accessed dialysis treatment at any of the dialysis clinics were compared. 
The dependent variable was dialysis subsidization, and the independent variables were 
subsidization, employment, and insurance. Covariates included age, race, gender, 
geographical location, CKD stage, CKD cause, and attending hospital. The data file for 
this study contained no personally identifiable information. Therefore there were no 
confidentiality violations. Current research about CKD provides vital information to 
decision-makers and other stakeholders in developing more appropriate strategies to 
address this chronic disease. Upon recognizing that the government bears the most 
significant responsibility for covering the cost of dialysis treatment through its 
subsidization program, health officials, government leaders, and other pertinent 
stakeholders may begin to explore alternative solutions for sustainability. Based on the 
fact that government can only subsidize dialysis treatment for a finite number of CKD 
patients,  preventative programs may be implemented to modify the general population's 
lifestyle choices to prevent further disease progression or even delay the onset. Other 
studies have established an association between a healthy lifestyle with decreased CKD 
risk and mortality in the general population (Lee et al., 2019; Morton & Sellars, 2019). 
Despite the inescapable financial obligations that CKD patients, their families, and the 
government face concerning dialysis utilization, the reality is that poor management of 
this disease invariably leads to even more financial burdens.  
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This study provided a greater understanding of how government subsidization has 
impacted access to dialysis treatment. This study's information may contribute to health 
service delivery improvements and policies to remedy financial barriers and improve 
access and quality of care for CKD patients in Saint Lucia (Wilk, Hirth, & Messana, 
2019). This study's results may also provide information to both the government and 
pertinent health officials about trends in CKD, financial barriers to accessing care, and 
recommendations for policy or social change improvement initiatives. Furthermore, the 
study is essentially a policy analysis of the government subsidization program's efficacy. 
Therefore, it is of potential societal relevance because the findings reveal that 
government subsidization positively impacts dialysis utilization for numerous Saint 
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